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The study of Lectins-specifically Arachis Hypogaea, the Peanut Agglutinin- aims 
to develop the use and application of lectins as diagnostic tools. Peanut agglutinin 
(PNA), a carbohydrate binding protein, is able to recognise and bind a number of 
distinct carbohydrate structures that have been implicated in a number of disease 
pathologies in humans. In vitro studies of PNA have previously been shown to have 
some specificity for the Thomson Freidenriech antigen (T-antigen), found on 
malignant human cells, and this specificity has made PNA an important target for 
protein engineering experiments aimed at improving its specificity and affinity. A 
number of tumour cells are characterised by altered states and patterns of 
glycosylation on cell surfaces and suitably engineered lectins may be able to 
recognise tumour specific carbohydrate structures. 
 
This study was aimed at carrying out the biophysical characterisation of a set of 
PNA mutants which showed apparent improvement in specificity for the T-
Antigen. Previous studies have aimed to engineer this lectin in order to direct its 
recognition properties towards the T-antigen and away from lactose, the 
preliminary binding affinities of these mutants being determined using Surface 
Plasmon Resonance (SPR). Here a set of  PNA mutants were characterised, proteins 
expressed and purified to determine binding activities to the T-antigen, N-Acetyl-D-
lactosamine (LacNAc) and lactose through the use of Protein Micro Array 
technology as well as Enzyme linked immunosorbant assays (ELISA). 
 
In addition, the current study aimed to determine the multimeric state of PNA in 
solution. Previous crystallography data suggests evidence of a tetrameric species, 
but the present studies demonstrate the predominance of dimeric species instead of 
tetrameric species. Finally, the present study also demonstrates a pH dependence of 




Chapter 1: Introduction 
 
1.1 The significance of protein carbohydrate interactions. 
 
Proteins are among the primary constituents of living organisms and form an 
important class of molecules studied in biochemistry/biological sciences. Proteins 
mediate many interactions on a chemical and biochemical level and are able to play 
structural, mechanical and catalytic roles thus providing most of the molecular 
machinery of cells (Liang et al., 2007) within a cellular environment, many proteins, 
interact with other proteins or with other molecules to form complexes. Of particular 
interest in the context of this thesis is the ability of certain proteins to bind to 
carbohydrate structures. These carbohydrate binding proteins have been shown to be 
excellent tools for monitoring changes on cell surfaces during physiological, 
pathological conditions and cell surface glycosylation patterns (Liang et al., 2007). 
Carbohydrates are a family of molecules of great structural and functional diversity. 
They constitute a significant fraction of earth’s organic matter. Proteins that interact 
with carbohydrate structures non-covalently are widespread in nature: these include 
carbohydrate specific enzymes as those found in metabolism, carbohydrate binding 
proteins, as well as anti-carbohydrate antibodies (Varki et al., 1993). In human 
biology, carbohydrate and protein carbohydrate interactions are typically essential in 
bacterial and viral infection, differentiation and development, immune response and 
for the progression of metastasis of tumor cells (Liang et al., 2007). 
One of the most well studied interactions between proteins and carbohydrates are 
between the lectin group of proteins and carbohydrates, as they bind to and recognize 
cell surfaces (Figure 1.1). A study by Sharon 1989 showed that lectins were able to 
agglutinate red blood cells giving rise to increased interest in this class of proteins in 
2 
 
Latin referred to as ‘legere’ meaning to select.  What makes lectins of increased 
interest is because they are found ubiquitously in animals, plants, bacteria etc., making 




Figure 1.1 Cell surface lectin–carbohydrate interactions. Lectins serve as means of attachment of 
different kinds of cell as well as viruses to other cells via the surface carbohydrates of the latter (Sharon 
& Lis, 2004). 
 
1.1.1 History of lectins as diagnostic tools 
 
Lectin research dates back to the late 1900’s and throughout the 20th century interest in 
the study of this class of proteins and their function has grown continually. The 
discovery of an agglutinin named ricin (Ricin communis) in the seeds from the castor 
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tree  in 1888 by Peter Hermann Stillmark, and also subsequently the discovery of 
another agglutinin named abrin extracted from the Jequirity bean, by H.Hellin, is 
where the interest in the use of lectins as agglutinating agents could be said to 
originate from (Sharon & Lis, 2004). 
 
These toxic agglutinins were employed by scientist Paul Ehrlich from the Royal 
Institute of Experimental Therapy as model antigens in immunological research in 
mice to determine  immunity and specificity of the immune response (Sharon & Lis, 
2004). Due to their toxicity, ricin and abrin were later used for biological warfare and 
intended for use as weapons for mass destruction during World War I and in World 
War II, a ricin bomb was developed and tested but never employed as a weapon of 
mass destruction (Sharon & Lis, 2004).  
 
One particularly intriguing lectin is Concanavalin A (Con A), from the Jack Bean; a 
pure form of this hemagglutinin was obtained by James Sumner in 1919 at Cornell 
University and in 1936, it was discovered that Con A was not only able to agglutinate 
erythrocytes and yeasts but could also precipitate glycogen from solution (Sharon & 
Lis, 2004), both activities being inhibited by sucrose. It was at this point that the idea 
of lectin sugar specificity came into play and  it was suggested that Con A-induced 
hemagglutination was as a consequence of binding between the lectin and 
carbohydrates found on the surface of red blood cells (Sharon & Lis, 2004). 
 
It was during the 1940s that the scientists William C. Boyd and Karl O. Renkonen 
from Boston University and University of Helenski respectively, made the discovery 
for the specificity of hemagglutinins for human blood groups/types (Sharon & Lis, 
2004). It was found that crude extracts of the Phaseolus limensis, Limabean, and the 
tufted vetch, Vicia (V) cracca, agglutinated blood type A erythrocytes but not blood 
type B or O cells, but an extract of the asparagus pea, Lotus tetragonolobus, was able 
to specifically agglutinate blood type O erythrocytes (Sharon & Lis, 2004). Additional 
hemagglutinins specific for blood types A and O (but not B) have also been 
discovered, as well as several for other blood types, such as N (V. graminea lectin), T 
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(peanut agglutinin, PNA) and Tn (the lectins of V. villosa and Moluccella laevis).  
(Sharon & Lis, 2004). 
 
These blood type–specific hemagglutinins played a pivotal role in early investigations 
on the structural basis of the specificity of the antigens involved with the ABO blood 
group system. During the 1950s, Winifred M. Watkins and Walter J. T. Morgan at the 
Lister Institute, London, discovered that the agglutination of type ‘A’ red cells by lima 
bean lectin was best inhibited by α -linked N-acetyl- D-galactosamine, and type O cells 
by the lectin of L. tetragonolobus, was best inhibited by a-linked L-fucose. It was 
concluded that α -N-acetyl- D -galactosamine and α-L-fucose, were the sugar 
determinants conferring A and H (O) blood group specificity, respectively (Morgan & 
Watkins, 2000). 
 
The work of Watkins and Morgan provided early evidence for the existence of 
carbohydrates on cell surfaces where they could play a role as identity markers-this is 
now an accepted theme in modern glycobiology. The potential for plant agglutinins to 
distinguish between erythrocytes of different blood types allowed Boyd and Shapleigh 
(1954) to propose the name lectins, meaning ‘to pick out’ or ‘choose’. This name was 
later generalized to include all sugar-specific agglutinins of none immune origin, 
irrespective of source and blood type specificity (Sharon & Lis, 1972).  
 
1.1.2 The study of carbohydrates and proteins and their interactions 
 
Protein-carbohydrate interactions have generated much interest over the past few years 
due to their great structural and functional diversity and the roles they play as energy 
stores/sources and as protein recognition molecules that mediate cellular adhesion and 
targeting (Varki et al., 1993). Glycoconjugates, glycoproteins and glycolipids all 
mediate interesting and valuable interactions such of which only exhibit functionality 




Lectins are typically classified according to their carbohydrate specificity and are often 
highly specific, multivalent carbohydrate binding proteins (Salunke et al., 1985). 
While some lectins are specific to only one sugar, others are able to bind to more than 
one sugar. Over the last 120 years lectin research has come a long way. Much more 
could be elaborated on the history of these proteins, but for this study, lectins as 
diagnostic tools and their structural characteristics will now be addressed.  
 
1.2 Types of lectins  
 
Three interesting lectin types have been found with the following classifications: 
Merolectins which possess only one carbohydrate binding site or domain. These are 
unable to agglutinate cells, as it is required that a lectin possess at least two domains to 
enable it to stably agglutinate a cell; hololectins, which possess at least two 
carbohydrate binding domains, which can either be identical or highly homologous 
and thereby are able to agglutinate red blood cells; and chimerolectins, possessing a 
carbohydrate binding domain and another unrelated domain that is unable to bind 
carbohydrates but which exhibits defined catalytic function, independent of the 
carbohydrate binding domain.  
 
These chimero lectins can act either as homolectins or merolectins, depending on the 
number of binding sites they possess (Van Damme et al., 1998). Lectins are typically 
classified into four groups, depending on their ability to bind to Glucose, Galactose/ 
N-acetylamine acetylgalactose, L-fucose, or the sialic acids (Table 1.1). The 
experimental classification by which this specificity was observed was by means of 
firstly, observing the protein’s ability to agglutinate red blood cells and then the 
monosaccharide specificity by observing which monosaccharide’s blocked this 
agglutination. The individual lectins show much greater specificity at the disaccharide 




Table 1.1 Legume lectins. Examples of legume lectins with structural data, sugar specificity and 
oligomeric states (Sharpe, 2003). 
 










bean ConBr Tetramer Man/Glc 1AZD 
Canavalia 
ensiformis Jack bean ConA Tetramer Man/Glc 2CNA 
Dioclea 
grandiflora Mucuna DGL Tetramer Man/Glc 1DGL 
Dolichos 
biflorus Horse gram  DBL Tetramer GalNAc 1LUI 
Dolichos 
biflorus Horse gram  DB58 Tetramer GalNAc IG7Y 








coral tree ECL Dimer GalNAc 1GZ9 
Vicia fabia Broad bean Favin Tetramer Man/Glc ND6 
Griffonia 
simplicifolia Griffonia GS-1 Dimer Gal/GalNAc 1HQL 
Griffonia 
simplicifolia Griffonia GS-4 Dimer Gal/GalNAc 1GSL 
Lathyrus ochrus Yellow-flowered pea LOL-1 Dimer Man/Glc 1LOE 
Maackia 
amurensis Amur maackia MAL Tetramer Complex 1DBN 
Pisum savitum Pea  PSL Dimer Man/Glc 2LTN 
Arachis 
hypogaea Peanut  PNA Tetramer Gal 2TEP 
Phaseolus 
vulgaris Kidney bean PHA-L Tetramer Complex 1FAT 
Robinia 
pseudoacacia  Bark lectin I 1FNY Tetramer Complex 1FNY 
Glycine max Soybean SBA Tetramer Gal/GalNAc 2SBA 
Ulex europaeus Common gorse UEA-1 Tetramer Fucose 1FXS 













However, to determine the biophysical function, the interactions between lectins and 
carbohydrates required more extensive study than just defining their ability to 
agglutinate erythrocytes or act as immune response agents. Crystallographic structural 
studies have thus provided answers  to some insight into this class of protein (Kumar 
et al, 2012). 
 
1.2.1 Legume lectin structure and function. 
 
Lectins largely consist of carbohydrate binding proteins or glycoproteins of non 
immune origin. They are able to bind cells or precipitates and on occasion both 
(Kumar et al., 2012). Carbohydrate associated enzymes with multiple combining sites 
will allow precipitation or agglutination of the glycoconjugates and may therefore also 
be labelled as lectins (Kumar et al., 2012). 
 
The specific binding capacity of the lectins is typically defined by the 
monosaccharides, which when present are able to inhibit the lectins associated 
reactions. Lectins are infact usually able to accommodate large sugars and their 
multivalency allows for stronger interactions with branched oligosaccarides (Kumar et 
al., 2012). Lectins do not typically exhibit strong cross-reactivity with protein 
elements of glycoprotein ligands so they are able to afford greater specificity for the 
carbohydrate structures in glycoproteins than antibodies are able to (Kumar et al., 
2012). Lectin histochemistry is based on the ability of the plant lectins, and in 
particular those from leguminosaes,  to discriminate between large numbers of 
structurally diverse cell surface sugars (Kumar et al., 2012). 
 
The legume family of lectins are the most widely studied group of lectins and have 
been purified from more than 70 species of legumes (Sharon and Lis 1990, Van 
Damme et al., 1998b).  Legume lectins are predominantly specific for Gal/GalNAc or 
Man/Glc monosaccharides but there exists the few that are specific for fucose (Sharon 
& Lis 1990).  Legume lectins are typically ~ 250 amino acid residues in length and 
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show high sequence homology across the family (see Figure 1.2/Figure A in 
appendix).  
 
Figure 1.2 Amino acid sequence homology (Manoj and Suguna, 2001). This sequence alignment 
shows the extent of homology across the legume lectin family. Sequences highlighted in black show 
complete homology across all legume lectins. 
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Figure 1.2 displays the completely conserved and the partially conserved sequences 
across the legume lectin family. The amino acids in bold black are those that are 
completely conserved and the grey highlighted amino acids, indicate partially 
conserved. Legume lectins are synthesised in the ER as pre-proteins, and after removal 
of the N-terminal signal sequence, further post-translational processing may occur.  
This may be through cleavage of C-terminal residues, removal of covalently bound 
carbohydrate, proteolytic cleavage (for example leading to the formation of two chain 
lectins of the Vicieae tribe) or cleavage followed by re-ligation of the N- and C-termini 
(for example producing the circularly permuted ConA) (Loris et al., 1998). Legume 
lectin monomers have a conserved tertiary structure, the prototypical example of 
which is the Jack Bean Canavalia Ensiformis lectin, Con A (Figure 1.3). 
 
 
                           
Figure 1.3 Concanavalin A tetrameric structure. Each colour differentiates a monomeric form of 
the tetramer of Concanavalin A. These monomers are identical to each other and are an indication of the 
conserved tertiary structure (Swiss PDB viewer). 
 
 This is similar to the fold observed in viral coated proteins (Chelvanayagam et al., 
1992), where it is essentially a scaffold of 3 -pleated sheets where the carbohydrate 




The classic legume lectin fold consists of a flat 6-stranded ‘back’ sheet, a curved 7-
stranded ‘front’ sheet, and 5-stranded ‘top’ sheet which is vital in keeping the two 
larger sheets together. Similar to the jellyroll fold seen in viral coat proteins, this fold 
is not in fact restricted to the legume lectins but is found in 14 other families despite 
low sequence homology (Chandra et al., 2001).  More than half of the lectin structure 
consists of loops and two hydrophobic cores, with the first formed between the back 
and front sheets and the second formed between the front sheet and loops curling over 
the front sheet (Loris et al., 1998).  
 
The legume lectins show much variation in quaternary structure despite displaying 
great homology in tertiary structure.  It is at the dimer interface that the main 
differences are evident with lectins, as they exist as dimers or dimers of dimers.  
(Covell et al., 1994).The extensive variation in quaternary structure appears to be due 
to small differences in tertiary structure and this phenomenon is evident in other 
protein families, such as the galectins,  and  chemokines, and cysteine knot growth 
factors (Covell et al., 1994). 
 
1.2.2 Common recognition folds of the lectins 
 
Legume lectins display a highly conserved monosaccharide binding site consisting of 
a narrow cleft in the protein surface containing four loops termed A, B, C, and D 
which contain certain residues including an, Asp (Loop A) an Asn (Loop C) and the 
main chain NH of a Gly or Arg (Loop B) (see Figure 1.4). The primary specificity to 
the monosaccharide is formed by hydrogen bonding interactions formed by a triad of 
the abovementioned invariant residues.  
 
Figure 1.4 presents a legume lectin, peanut agglutinin (PNA) with Loops A, B, C, and 
D. The bound sugar (lactose) is shown as a “ball-and-stick” image. Important calcium 
and manganese ions are required for ligand binding. The size of binding-site loop d 
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and monosaccharide specificity show an explicit correlation. Key residues are 
highlighted in blue and highly conserved residues and been indicated with an asterisk 
(Vijayan et al., 1999). 
 
 
Figure 1.4 Loops involved in sugar binding. This shows the three-dimensional structure of a 





A cis peptide bond is located between the conserved asparagine in loop A and the 
previous residue which is typically an alanine, and serves to orientate the asparagine 
correctly. Stabilisation of the bound sugar is generated by stacking interactions with a 
Leu, Tyr, Trp, or Phe residues.  Most legume lectin specificity towards Man/Glc or 
Gal/GalNAc, may be explained largely by the orientation of the 3’ and 4’ hydroxyl 
groups in the ligand.  Ligands are only bound if their orientation is such that an 
equatorial OH (3’OH in Gal/GalNAc or 4’OH in Man/Glc) (Sharpe, 2003), is directed 
towards the centre of the triad.   
 
An axial OH is required to establish contacts with the Asp from loop A.  The binding 
site is incapable of accepting two equatorial hydroxyl groups facing the triad, leading 
to a difference in the orientation of Man/Glc and Gal/GalNAc in order to make the 
required binding contacts (Sharpe, 2003). The specificity observed between mannose 
and galactose binding lectins is thought to be generated by Loop D, which is highly 
variable with regards to length and sequence.  Only some residues of this loop interact 
with the sugar and these differ between lectins within the same monosaccharide 
specificity group.  It seems, the length of Loop D in Gal/GalNac specific lectins is 
longer than in the Man/Glc specific group and the length rather than its sequence has 
been suggested to be the main determinant for discrimination between these two 
specificity groups (Sharma & Surolia, 1997).  
 
1.3The Peanut Agglutinin (PNA) and T-antigen 
 
1.3.1 Structure and molecular recognition properties of the PNA 
 
Literature suggests that the peanut agglutinin, PNA, is a non-glycosylated 
homotetramer of roughly 110 kDa (Figure 1.5), with each monomer consisting of 236 
amino acids made up of 4 subunits of around 27.5 kDa (Young et al, 1991.). It has one 
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carbohydrate binding site per monomer/subunit (Figure 1.6) along with a single 




Figure 1.5 The legume lectin fold.  The lectin fold shown as a) Diagrammatic view and b) 
represented by one subunit of peanut agglutinin (PNA) (Sharpe, 2003). 
 
 
a) b)  
                                                                      
Figure 1.6 Tetrameric fold of PNA. Displaying the four subunits of PNA (Sharpe, 2003). 
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It is interesting that PNA differs from many other lectins through the use of the 
stabilizing water bridges between the monomers (Dev & Surolia, 2006). What makes 
the PNA unique in the tetrameric lectin group is the dimeric interface between 
monomer 3 and 4, (see Figure 1.6) (Dev & Surolia, 2006). Ligand specificity on the 
other hand, is generated by both direct and water mediated hydrogen bonding to key 
hydroxyls on the sugars. Divalent cations such as Ca2+ and Mg2+  are critical to ligand 
binding by PNA since they help to control the shape of the binding site and as 
previously mentioned, lectins differ in their specificity for ligand binding as well as 
quaternary structure, (Dev & Surolia, 2006).  
 
The crystal structure of PNA reveals an apparent homotetrameric, non-glycosylated 
nature, whilst a wealth of literature has shown that PNA is able to recognize the sugars 
lactose, N-acetylactoseamine (LacNAc), glucose and the Thompson Freidenreich 
antigen (T-antigen) – a cell marker with a proven link to malignancy which is 






Figure 1.7 Structures of Lactose, LacNAc and the T-antigen.  Chemical structures of the sugars 
that recognise PNA (Swiss PDB viewer). 
 
Although aberrant glycosylation is typically shown to be present in all human cancers, 
studies suggest that it is a result of oncogenic transformation, rather than the cause 
(Hakomori et al., 2002), and the altered sugar epitopes produced are thus considered 
as tumour associated antigens. PNA has been tested as a diagnostic and prognostic 
indicator in many cancers (Sotozono et al., 1994; Campbell et al., 1995) because it 
allows for the monitoring of differential expression of the T-antigen as well as 
allowing for early detection of ‘T-polyagglutinability’, and the separation of mature 
and immature thermocytes for use in bone marrow transplant (Reisner et al., 1979).  
 
1.3.2 Thomsen Freidenreich antigen (Gal1-3 GalNAc1-O-Ser/Thr)  
 
T- and Tn (GalNAc1-O-Ser/Thr) blood group precursors, occur in normal tissues as 
the more abundant cryptic T- and Tn that are masked by sialylation, however in most 
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cancerous tissues, these T- and Tn antigens are not sialyted (Springer et al., 1997).  
PNA has an advantage over other anti-T antigen lectin probes, such as Amaranthin and 
Jacalin, since PNA is able to distinguish between sialylated and non sialylated T-
antigens (Lotan et al., 1975, Rinderle et al., 1989, Swamy et al., 1991).  
 
The limiting factor in use of PNA as a cancer diagnostic tool though is its cross 
recognition of the healthy cell epitope LacNAc and although the wildtype PNA binds 
to the T-antigen with ~ 10 fold higher affinity than to LacNAc, this cross reactivity 
remains limiting. Other methods of selective recognition of the T-antigen have also 
been explored.  For example, monoclonal antibodies were produced to be specific for 
the T-antigen, but these still displayed some cross reactivity towards normal cells and 
gave conflicting results in their binding to carcinoma cells (Baldus et al., 2000). Small 
peptides have also been selected from libraries for binding to T-antigen (Peletskaya et 
al., 1997) and the initially low affinity of these peptides has recently been improved to 
around KD  60 nM (Landon et al., 2003) but the use of these peptides, particularly 
with regard to their inability to agglutinate, remains to be seen.   
 
Lectin crystal structures of 26 legume lectins in complexed and uncomplexed states 
are currently known and accessible, (3D Lectin Databank, 
http://www.cermav.cnrs.fr/lectines/ accessed in March 2013) and classified as 
tetramers, comprised of dimers of dimers or strictly dimers. The first X-ray study on 
PNA was in the early 1980’s (Salunke et al., 1981) but the crystal structure was not 
solved until 1994 (Banerjee et al., 1994). 
 
 PNA has been described by crystallography as being a dimer of dimers with each 
dimer being formed by back to back association of monomers 2&3 and 1&4 through 
flat back beta sheets. The monomers in each dimer are related by a two-fold axis, and 
the two dimers are related by another two fold axis (Salunke et al., 1985). The 
interface of each dimer between each monomer is made up of side by side alignments 
of two flat β sheets which is a common form of dimerization as seen in many other 
17 
 
legume lectins (Dev & Surolia, 2006). However, there is some evidence that PNA 
might in fact exist in solution as a dimer, not a tetramer (Sharpe, 2003) which warrants 
further investigation. 
 
The affinity of lectins binding for simple monosaccharides is usually weak, with 
dissociation constants, (KD) typically in the range 0.1-10 mM reflecting the relatively 
shallow binding site in legume lectins which contrast the bacterial periplasmic sugar 
binding proteins that envelope the ligand and binds with much higher affinity (Vyas et 
al., 1991). However, increased selectivity and binding affinity in lectins is achieved by 
expansion of the primary binding site to include a secondary binding site, thereby 
enabling selective higher affinity binding of dissacharide. 
 
 The quaternary structure of legume lectins gives rise to a clustering of binding sites, 
enabling the high affinity recognition of multivalent sugar ligands through the binding 
of one ligand to each of the subunit binding sites.  The relative orientation of the 
various binding sites in the quaternary structure also determines specificity; in some 
lectins, such as ricin (a galactose-binding protein), and cholera toxin, the binding sites 
all face the same direction, enabling binding to multivalent carbohydrates on a cell 
surface;  in others, such as Con A and PNA, the binding sites are at opposite ends of 
the molecule suggesting a bridging function, that is consistent with the known function 
of some galectins in cell-cell interactions and the ability of certain legume lectins to 
agglutinate red blood cells (Drickamer et al., 1995). 
  
PNA is also able to recognise sugars including LacNAc, lactose and galactose (see fig 
1.8), with around 10, 30 and 50 fold lower affinities than towards T-antigen 
respectively (Sharma and Surolia 1996, Adhikari et al., 2001).  
 
The PNA is able to bind with greatest affinity to the T-antigen with a reported 
dissociation constant (KD) between 3-22M at 4 to 25 C (Neurohr et al., 1982, 
Adhikari et al., 2001). The structural basis for the discrimination of PNA between 
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Figure 1.8 Structures of a) the T-antigen, b) LacNAc c) lactose.  Sugars as they appear in the 
binding site of PNA, showing the similar orientation of the primary galactose ring (Sharpe, 2003). 
 
The PNA crystal structure has been solved in complex with the T-antigen 
(Ravishankar et al., 1999a), lactose (Banerjee et al., 1996) and LacNAc (Ravishankar 
et al., 1999b).  It is interesting to note that, in all crystal structures only the first 232 
residues are seen clearly in the electron density map, with the last 4 residues appearing 
to be disorganised.  
 
Typically, as is seen in all other legume lectins the highly conserved carbohydrate 
binding site is established from residues from the four loops A (75-83) B (91-106) C 






Figure 1.9 PNA monomer in complex with the T-antigen. Showing a) the position of the four 
carbohydrate binding loops and b) Surface model of the carbohydrate binding pocket.  For each, loop 


















Figure 1.10  PNA in complexes with a) T-antigen, b) Lactose and c) LacNAc. The sugar is 
coloured green in all structures and the invariant triad of Asp83, Asn127, and Gly104 are shown in red.  
Other residues highlighted include: Ser211= yellow, Leu212= light blue, Gly213= dark red, Gly214=  
green (Sharpe, 2003). 
 
The water-mediated interactions increase the affinity for Gal at the primary binding 
site in PNA and are mediated by two water molecules, w1 and w2 as can be seen 
below (Figure 1.11).  The Gal O2 interacts with Glu 129 OE1 through w1 and with 
Gly104 N through w2 in the T-antigen, lactose, and LacNAc complexes respectively. 
The galactose moiety of each sugar is anchored in the primary binding site by the 
same contacts.  The difference in the contacts made by the second ring of each sugar is 









Figure 1.11 The carbohydrate binding site of PNA in complex with the T-antigen 
representation.  Here the water molecules that aid in the mediation between sugar and protein can be 
seen (Sharpe, 2003). 
 
The specificity of PNA for the T-antigen over lactose and LacNAc is directly related 
to the presence of these additional water bridges (w3 and w4).  PNA does not bind to 
GalNAc like other lectins similar to it (Adhikari et al., 2001).   
 
1.4 Engineering of plant lectins to improve specificity 
 
The fields of medical diagnostics and biotechnology have explored the use of lectins 
due to their potential value in the identification of the presence of specific 
carbohydrates, glycolipids and glycoproteins on cell surfaces (Cook, 1986). Their use 
as reagents for blood typing and mitogenic stimulation of lymphocytes are still 
employed, but today one of their major uses is in the detection of change in cell 
surface glycosylation patterns, which is evident in a number of conditions such as 
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malignant transformation, cell maturation and aging. Additional uses of lectins include 
typing of bacteria, identification and separation of cells, an example of the latter  being 
the removal of mature T-cells from bone marrow by soybean agglutinin prior to 
transplantation treatment of children with severe combined immunodeficiency. Lectins 
also find application in the purification of recombinant glycoproteins for therapeutics, 
(Sharon & Lis, 1986, Van Damme et al., 1998b).     
 
The desire and ability to modify lectins for use in medicine is driven today by the 
growing understanding of the evolution of binding proteins. Common recognition 
principles are evident in, for example the binding of carbohydrates to proteins through 
the combined use of hydrogen binding and Van der Waals interactions. Specificity of 
the carbohydrate recognition on the other hand is generated by the direct water 
mediated hydrogen bonding to important hydroxyls and by the presence of Ca 2+ and 
Mg 2+ cations which interact with the sugar indirectly as seen in legume lectins or 
directly. This will impact on the shape or orientation of the binding site therefore 
altering the positioning of the sugar (Sharpe, 2003) 
 
It is therefore tempting to speculate that the binding specificity of legume lectins 
might be engineered through site directed mutagenesis that alters the pattern of 
hydrogen- binding between lectin and bound carbohydrate. One lectin that has been 
the subject of several mutagenic studies is PNA. 
 
It has been demonstrated that PNA also shows some non-specificity for the T-antigen, 
as it binds lactose and N-acetyl-lactosamine (LacNAc), commonly found at the termini 
of cell surface sugars.  Because of this, studies, redesigning the substrate specificity of 
this lectin have been undertaken (Sharma et al., 1996, Adhikari et al., 2001).  Sharma 
et al. (1996) described the creation of two mutants within the carbohydrate binding 
loop, at positions, L212A and L212N.  The L212N mutation apparently leads to an 
increased affinity towards lactose, unchanged binding to the T-antigen but loss of 
binding to LacNAc, while L212A leads to elimination of binding affinity towards the 
T-antigen, but an increased affinity for LacNAc.  In a later study Adhikari et al. (2001) 
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targeted residue N41 which is important in making critical water mediated contacts 
with the T-antigen.  All three mutants analysed (N41A, N41D, and N41Q) reportedly 
retained an unchanged affinity for lactose, but exhibited a marked decrease, slight 
decrease and 4-fold increase in binding affinity for the T-antigen respectively.  The 
results of these interesting studies indicate the potential of engineering PNA for the 
creation of improved specificity towards the T-antigen. 
 
In more recent work, Sharpe and colleagues (2003) used a novel in-vitro phenotype-
genotype linkage plasmid display system to select PNA variants with altered binding 
properties from a random mutation library. Starting from a library in which a number 
of residues had been randomised, a number of PNA variants were identified based on 
their binding to immobilised T-antigen and preliminary characterisation by Surface 
Plasmon Resonance (SPR) suggested that these mutants had improved recognition 
properties towards the T-antigen- these mutant PNA therefore warrant further 
investigation. 
 
1.5 Aim of thesis 
 
The aims of this Master’s thesis are therefore: 
1) To provide further experimental evidence for altered specificity of three variant 
forms of PNA that originated form the work of Sharpe and colleagues. 









Chapter 2: Materials and Methods 
 
Unless otherwise stated, the fine chemicals and reagents were supplied by Fluka, 
Saarchem Chemicals, Merck Chemicals and Laboratory supplies OR Sigma Aldrich 
chemical company. DNA size markers, protein ladders and restriction 
endonucleases/enzymes were supplied by Fermentas. The pceseq and 6xHisfor 
oligonucleotide primers were made and purchased from Stellenbosch Sequencing Unit 
University of Stellenbosch, South Africa. Carbohydrates were purchased from 
(Lectinity, Moscow). Substrate for ELISA was purchased from R&D systems. 
Microarray slides were from Schott/ Nexterion. All solutions were prepared using 





Tryptone        10g 
Yeast              5g 
NaCl              10g 
LB agar – all above including Agar 15g/l 
Above chemicals were prepared into 1L of distilled water. 
Autoclaved prior to use after which appropriate antibiotic added. 
 
Ethanolamine (200 mM, pH 8.0) 
Ethanolamine (98%)  
NaOH  
Add 2.55 mL of ethanolamine to ~150 mL of H2O. Adjust the pH to 8.0 with NaOH 





1 M Na2HPO4 (100 ml)  
Na2HPO4                14.2 g 
Add distilled H2O to final volume of100 ml 
 
1 M NaH2PO4 (100 ml)  
NaH2PO4                12 g  
Add distilled H2O to final volume of100 ml 
 
1M Sodium Phosphate buffer pH 8.0 
1 M Na2HPO4       93.2 ml 
1 M NaH2PO4       6.8 ml 
                            100ml 
Adjust pH with NaH2PO4 and Na2HPO4. 
Autoclave and store at room temperature. 
 
Guanidine (6M pH6.4)  
Guanidine-HCl573.      18 gram (g) 
1M Tris-HCl (pH7.6)    50ml 
0.5 M EDTA                 40ml 
dH2O to                          1l 
Total volume                  1l 
 
1M KCl  
KCl 7.5 gram (g) 
dH2O to 100m 
Total volume 100ml 
 
1 M H2SO4 
Sulfuric Acid (H22SO4 95-97%) 5.6 ml 
dH2O to                                     100 ml 
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Total volume                             100 ml 
Note: Dilute by adding slowly sulfuric acid to 80 ml water and mix, adjust final 
volume to 100 ml.  
 
TFBI 
30 mM potassium acetate          1.47 g 
50 mM manganese chloride      4.95 g 
100 mM rubidium chloride       6.05 g 
10 mM calcium chloride           0.56 g 
15% (w/v) glycerol 75 ml 
Bring the volume up to 500 ml using distilled water. 
Adjust the pH with 0.2N acetic acid to pH 5.8. Throw the solution out if the pH is less 
than 5.8. (i.e. 5.82 or so is useful) 
Sterile filter the solution and keep at 4 C  
 
TFBII 
10 mM mops pH7.0               0.42 g 
75 mM calcium chloride       1.66 g 
10 mM rubidium chloride      0.24 g 
15% (w/v) glycerol                30 ml 
 
Bring the volume up to 200 ml by adding distilled water. 
Adjust the ph with 0.2N acetic acid to pH 5.8. Throw the solution out if the pH is less 
than 5.8. (i.e. 5.82 or so is useful) 
 
Chlroramphenicol  
34 mg/ml in EtOH: -20ºC  
Choloroamphenicol stock 34mg/ml 
Required at 30 ug/ml 
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1 M HEPES, pH = 7.0   
HEPES (free acid)                119.15 g 
Distilled water to                  400 ml  
Add solid NaOH a few pellets at a time while mixing until the pH is ~6.8  
Add concentrated NaOH dropwise to achieve pH = 7.0  
Distilled water to 500 ml  
Sterile filter and store at 4ºC 
 
1 x Spotting Buffer pH 8.3 
Final concentrations of         100 mM KCl 
Triton X-100                          0.01% 
HEPES pH 8.5                       25 mM 
Made up to 100ml final volume in distilled water. 
 
10 M Ammonium acetate 
Dissolve Ammonium acetate   770 g 
H2O                                         800 mL 
Adjust volume with H2O. 1 L 
Sterilize by filtration.  
Store the solution in tightly sealed bottles at 4°C or at room temperature. Ammonium 
acetate decomposes in hot H2O and solutions containing it should not be autoclaved. 
 
SDS page separating gel                    10% gel 
Water                                                    4.1ml 
1.5M Tris-HCl pH 8.8                          2.5ml 
20% (w/v) SDS                                     0.05ml 
Acrylamide/Bis concentrate   
(30%/ 0.8 % w/v)                                  3.3ml 
10% Ammonium persulphate               0.07ml 




Ammonium persulphate and TEMED added immediately prior to casting 
 
SDS page stacking gel 
Water                                               3.07ml 
0.5M Tris-HCl pH 8.8                     1.25ml 
20% (w/v) SDS                                0.025ml 
Acrylamide/Bis concentrate   
(30%/ 0.8 % w/v)                            0.67ml 
10% Ammonium persulphate         0.025ml 
TEMED                                           0.01ml 
Ammonium persulphate and TEMED added immediately prior to casting 
Coomasie staining and destaining solutions prepared by technical staff. 
  
1M Sulphuric acid  
Add 5.33ml of 95% H2SO4 to 100ml of water (always add acid to water) 
  
50mM Biotin 
Dissolve biotin in      0.12215g 
dH2O                         5ml   
Add 1M NaOH to dissolve solids with shaking 
Make up to                  10ml 
Filter sterilize 
 
Blocking solution (Streptavidin 1mM) 
Streptavidin                       1ml 
1x PBS triton solution       49ml 
 
0.5 M EDTA pH 8.0 1 liter  
Na2EDTA.2H2O          186.1 g 
Milli-Q H2O                 800 ml 
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Bring pH to 8 with NaOH pellets (about 20 g); Bring volume to 1 liter with dH2O and 
autoclave. 
 
1 M Tris (pH as desired) 
1 M Tris pH 8.5 1 liter 
Tris base                         121.1 g 
H2O                               ~750 ml 
Adjust pH to 8.5 with ~20 ml conc. HCl  
Bring to 1 liter with distilled H2O; don’t autoclave.  
Store at RT  
 
2 M Tris pH 7.5  
To make 1 liter:   
242.2 g Tris base  
600 ml Milli-Q H2O   
 Dissolve Tris in H2O and adjust pH with ~ 125 ml conc. HCl   
Bring volume to 1 liter with Milli-Q H2O; don’t autoclave  
 
3 M NaCl  
To make up 2 liters   
350.6 g NaCl  
Make up to 2 liters with dH2O  
Store at RT   
 
7.5 M Ammonium acetate  
To make 1 liter:   
578.1 g NH4Ac  
Dissolve in dH2O to final volume of 1 liter.  
Check the pH; it should be about 7.4  




10 N NaOH  
 400 g NaOH per liter dH2O  
 
10X TBE 
     1 L    
Tris              1 08.8 g               
Boric Acid    55.0 g   
0.5M EDTA     40 mL  
Make up to 1L with distilled water.  
 
Lysis-Equilibration-Wash Buffer (1 x LEW Buffer, 1 liter Protino Kit) 
50 mM NaH2PO4         7.8 g NaH2PO4 x 2 H2O (MW = 156.01 g/mol) 
300 mM NaCl             17.5 g NaCl (MW = 58.44 g/mol) 
Adjust pH to 8.0 using NaOH 
Prepare in 1L of distilled water 
 
1 x Elution buffer (Protino Kit) 
50 mM NaH2PO4         7.8 g NaH2PO4 x 2 H2O (MW = 156.01 g/mol) 
300 mM NaCl             17.5 g NaCl (MW = 58.44 g/mol) 
8 M urea                    480.5 g (MW = 60.06 g/mol) 
250 mM imidazole      17.0 g imidazole (MW = 68.08 g/mol) 
Adjust pH to 8.0 using NaOH 
Prepare in 1L of distilled water 
 
5X TBS 
     1 L   
Tris     24.2 g   
NaCl     292.4 g 
Make up to 1L in distilled water.  




Add Ethidium bromide (EtBr) to the Gels NOT the running buffer. 
Add 5ul (10mg/ml) EtBr per 100ml TAEl (caution:  mutagenic)  
 
5x loading dye for agarose gels  
50% glycerol             50 ml  
0.5 M EDTA pH 8 10 ml  
1 M Tris pH 7.5 5 ml  
Add a tiny amount (a few mg) of the dye xylenol orange--just enough to color the 
solution. Add 35 ml dH2O to total volume 100 ml.   
 
6X Loading Dye (Fermentas): 
0.09% bromophenol blue (just add enough until you get a color you like)  
0.09% xylene cyanol FF   
60% glycerol  
60mM EDTA 
 
10X PBS   
Phosphate buffered saline, recipe from Harlow and Lane.  
To make up 1 liter   
NaCl    80 g  
KCl    2 g  
Na2HPO4   14.4 g  
KH2PO4   2.4 g  
 Dissolve in 800 ml dH2O  
Adjust pH to 7.4 with HCl  
Bring volume to 1 liter, autoclave 
To make up 1x PBS, dilute 100ml of a 10x solution in 900ml of dH2O. 
 
PBS-Tween:  
1.5 mM KH2PO4, 
4.3 mM Na2HPO4 
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137 mM NaCl 
 3 mM KCl  
 0.1% (v/v) Tween20  
 Adjust to pH 7.4 with HCl. 
         
1 M CaCl2  
To make 1 liter   
110.9 g CaCl2  
dH2O to 1 liter  
Aliquot 100 ml/bottle, autoclave  
1 M MgCl2 
To make up 100 ml   
20.3 g MgCl2.6H20 
Make up to 100ml with dH2O  
Autoclave 
Store at RT  
Glycerol (100%) dilute in dH20. Sterilize by autoclaving. 
 
Destain 
     1 L 
Methanol    50 mL 
Acetic Acid            42 mL  
Make up to 1L with distilled water. 
 
Stain   
     1 L 
Methanol    150 mL 
Acetic Acid                  100 mL 
Coomassie Blue              2 g 




10X Transfer Buffer 
     1 L 
Tris     24.7 g   
Glycine    112.6 g  
Do not pH the transfer buffer 
Make up to 1L with distilled water. 
 
Blot Transfer Buffer  
     1 L 
Methanol               200 mL 
Glycine    14.4 g 
Tris     3.03 g 
Make up to 1L with distilled water. 
 
10% (w/v) Ammonium Persulfate (APS) 
     500 mL 
Ammonium persulfate  50 g 
Make 50 mL aliquots in distilled water.  Store at -20°C. 
 
Lysozyme, 50 mg/mL 
                           10 mL 
Lysozyme    0.5 g 
Make up 10ml volume in distilled water. 






2.2.1 DNA characterization and analysis 
 
Preparation and growth of competent cells for transformation of plasmid DNA. 
 
Competent E.coli JM 109 cells were prepared using the Rubidium Chloride method 
(Promega Protocols and Applications Guide (3rd edition), p. 45-46). The cells were then 
transformed to Chloramphenicol antibiotic resistance with plasmid DNA of interest using 
the Inoue method of transformation (Inoue et al. 1990 Gene 96, 23-28). Single colonies 
containing transformed cells were plated onto a LB Cam agar and incubated overnight at 
37C.  
 
pCESN20 (6xHis), pCES N41R (6xHis) or pCES I101R (6xHis), (see Figure 3.1 and 3.2) 
clones were picked and inoculated into 5ml LB Cam media and incubated overnight at 
37C with shaking at ~ 180 rpm and glycerol stocks of samples were prepared for long 
term storage at –80 C. This was done by adding 100µl of sample into a 1ml tube with 
400µl of an 80% glycerol stock. 
 
2.2.1.1 Analysis and manipulation of DNA 
 
Plasmid DNA was purified from resulting 5ml cultures using the QIAGEN mini-prep kit 
according to manufacturer’s protocol. The purified plasmid was eluted in 30-50ul TE 
buffer/water and the concentration was determined through quantification using a Nano 
Drop® ND -100 spectrophotometer (Nano Drop Technologies®). The use of zymogen 
clean and concentrator kits facilitates the removal of DNA polymerases, modifying 
enzymes, RNA polymerases, ligases, kinases, nucleases, phosphatases and restriction 
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endonucleases etc. to enable cleaner more concentrated DNA. 
 
Plasmid DNA size of the three clones, was determined through 0.8% gel agarose gel 
electrophoresis using a 1x TBE buffer. 
 
Restriction endonuclease digestion of DNA  
 
Samples were quantified using a Nano Drop ® (Nano Drop Technologies ®) ND-100 
spectrophotometer and prepared for sequencing.  
 
Using the appropriate buffers for each digest, restriction digest of 1ug of plasmid DNA 
was carried out using  1 unit of enzyme each: NdeI and Xho I were used for the double 
digest and NcoI was used for the single digest. To identify plasmids based on sizes of 
fragments, digests were separated on a 1% agarose gel (supplemented with EtBr) in TBE 
running buffer at 80 Volts for 45 minutes. The uncut plasmid size was 5139bp. 
 
Sequencing of plasmid DNA 
 
Pceseq and 6xHisfor primers (see appendix page 107) were synthesized by Dr. Di James 
at the Sequencing Unit, University of Cape Town Molecular Cell Biology or 
Stellenbosch sequencing Unit, University of Stellenbosch. Plasmid identity was 
confirmed by Sanger sequencing using the primers pceseq For and 6x His (Stellenbosch 
sequencing unit, Department of Genetics at the University of Stellenbosch). 







2.2.2 Expression and purification of recombinant proteins 
2.2.2.1 Protein expression  
 
Protein was expressed from glycerol stock containing E.coli JM 109 transformed with 
pCES N20 (6xHis), pCES N41R (6xHis) or pCES I101R (6xHis) clones. Each 
transformation mix was streaked out on LB Cam (Chloramphenicol at 34ug/ml) plates 
and incubated overnight at 37C. Single colonies were aseptically inoculated into 5ml 
LB supplemented with Chloramphenicol (30µg/ml) and grown at 37C overnight in an 
orbital shaking incubator at 200rpm. Cultures were scaled up by adding the 5ml into 
500ml in LB Cam, and grown overnight at 30 C, with shaking at 230 rpm.  
 
2.2.2.2 Cell harvesting and fractionation 
Cells were harvested by centrifugation at 12 000 rpm (Beckman J2-21M) for 30 minutes 
at 4C. The supernatant was removed and the pellets stored at –20C or resuspended in 
10ml Lysis buffer (as prepared from a 4x concentrate, provided with Protino Purification 
kit) along with the addition of 1 mg/ml lysozyme, 500 U DNase I (New England 
Biolabs), 0.5mM CaCl2, 2.5mM MgCl2, giving a final volume of 11ml for each culture. 
The cell suspensions were incubated on ice for 30 min with gentle agitation prior to 
sonication.  
 
Samples were subjected to sonication (Virsonic 100) for 3x 10 second on and 10 
seconds off bursts on ice at 70% duty cycle. The sonicated cell lysate was then clarified 
by centrifugation at 10 000 rpm for 20 minutes at 4 C and soluble lysate was removed 
and filtered through a 0.45µM filter. The insoluble pellet was discarded. The cell 
suspensions were then centrifuged at 10,000 rpm for 30 min at 4°C and the resulting 
supernatants were the crude soluble lysate preparations. 100 μl of each lysate was 
removed and stored at -20°C. All soluble proteins were then filter sterilized through a 45 
micron filter prior to use in Protino columns. 
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 2.2.2.3 Protein purification 
  
Protein was purified using either Protino His tag columns or Ni-NTA agarose beads 
(Qiagen purification system) for 6 x His tagged proteins. Protino columns were pre 
equilibrated with 1x lysis/wash buffer (see Materials and Methods), after which 5-6 ml 
of the crude lysate was added to the column, and washed twice with 2ml lysis solution. 
The HIS tagged protein was eluted from the column twice with a 2ml of 1x elution 
buffer as per the Protino kit. The Bradford assay was used to quantify yield of purified 
protein. 
 
To prepare the Ni-NTA agarose beads, 500µl slurry of resin was centrifuged in a 15ml 
tube at 4000rpm for 10 minutes and storage buffer solution was removed by aspiration. 
The resulting resin pellet was resuspended in 2ml of the crude lysate and was then 
centrifuged again at 4000rpm for 10 minutes. The supernatant was removed and beads 
were washed twice in 2ml of wash buffer and recovered by centrifugation as previously 
described. Beads were then resuspended in 0.5ml of elution buffer and then pelleted by 
centrifugation as before, this was repeated 4 times, the supernatant in each  being kept 
for SDS-PAGE analysis. Samples were analysed on 10 % SDS gel or stored at 4 °C, for 
further analysis. 
 
2.2.2.4 Determination of protein concentration by Bradford assay and 
spectrophotometer readings of pure lysate 
 
Samples were prepared at a dilution of 1:10 with Bradford (undiluted) reagent. The 
concentration of the protein was determined at 595nm for both crude and purified 
protein. A 60µl of pure protein sample was added to 540µl elution buffer and vortexed. 
500µl of this was mixed with 500µl Bradford’s reagent and allowed to equilibrate for 20 
minutes. The OD 595 was measured on spectrometer. Protein concentration was 
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determined by comparison to standard curve treated under same conditions as sample 
was prepared, by known concentrations of BSA as per reagent suggestions and whether 
standard/micro-assay. 
 
2.2.2.5 Polyacrylamide gel electrophoresis (PAGE). 
 
10% polyacrylamide gels were prepared for crude proteins and for purified proteins as 
follows: two glass plates were immobilized onto a gel tank stand (BIORAD) and the 
preferred percentage separating gel was prepared and allowed to polymerize with a 
covering layer of isopropanol. After 20 minutes, the isopropanol layer was decanted off 
and the top of the separating gel was washed off with water. The stacking gel was then 
poured above the separating gel and a comb inserted; the stacking gel was allowed to set 
for 20 minutes. After polymerization the comb was removed and the glass sheets 
removed from the stand and immobilized onto the gel tank (BIORAD) and immersed in 
a 1x SDS PAGE running buffer. Pre-stained protein ladder was loaded directly into the 
first lane without boiling. 10-15µg of each sample was loaded mixed with 5µl of a 4 x 
SDS loading buffer and the soluble fractions boiled at ~90°C for 5 minutes, debris 
removed by centrifugation and 20µl of the supernatant was directly loaded into each 
well. The gel was run at 35mA constant current for 2 hours until the Bromophenol blue 
of the loading buffer reached the bottom of the gel. The gel equipment was then 
disassembled and the gel removed and stained with Coomasie staining solution for 4 
hours followed by destaining the gel in destaining solution overnight to enable 
visualization of protein band’s. 
 
2.2.2.6 Western blot analysis 
After proteins were subjected to SDS page gels, protein gels were placed between sheets 
of filter paper and nitrocellulose membrane (Amersham, Hybond ECL) and soaked in 





Positive electrode        Filter paper 
                                         Nitrocellulose membrane 
                                         Gel  
Negative electrode       Filter paper completely immersed and soaked. 
 
The blotting apparatus was set up using a BIORAD Miniprotean ® tank, with an ice 
pack, and transfer of proteins onto the membrane was achieved by electrophoresis at 100 
volts for 1 hour in transfer buffer. The blot was removed, the membrane stained in 
Ponceau’s stain for a minute to check for the presence of any band’s. The membrane was 
then removed from the Ponceau stain and incubated in 5% skim milk powder to block 
any unbound protein an hour on a shaker at room temperature. Milk (skim) contains a 
generic mix of a relatively high concentration of known proteins; it is used to block the 
parts of the membrane that don't already have protein on so that the antibodies won't bind 
there. 
 The membrane was then washed 3 x 5min in 1x PBS. Anti His HRP conjugate was 
diluted to 1:1000 in 10 ml of a 5 % milk powder and incubated on the membrane used to 
probe the blot for 1 hour. The blot was then washed for 3x 5min in 10 ml PBS + 0.1 % 
Tween, followed by a final wash in distilled water for 5 min. The blot was then air dried 
and probed with an HRP chemiluminescent substrate (Supersignal West Pico) (Sigma 
Aldrich) according to manufacturer’s protocol; chemilumeniscent signal was recorded 
on autoradiography film and the film was developed according to standard protocols.  
Alternatively, the membrane was probed with Anti-Arachis Hypogaea, agglutinin 
(Sigma Aldrich, #L7759) as the primary antibody and the secondary Goat anti Rabbit 
IgG antibody (Santa Cruz,#sc2030), HRP conjugated, dilution at 1:1000 in 10 ml 1xPBS 






2.2.3 Native gel electrophoresis 
 
2.2.3.1 Mobility shift assay  
 
Native mobility shift assay was carried out according to standard protocols (Ausubel et 
al., 1994) A 4%Tris Gycine gel was prepared, and re-run for 30-60 min at 100 volts. 
The gel was loaded with a prestained protein ladder, unstained protein ladder, and 
varying concentrations of wildtype PNA treated with different concentrations of 
Guanidine Hydrochloride, as well as untreated wildtype PNA and Concanavalin A. A 
stock solution of 6M guanidine was prepared and diluted down to 4M, 2M, 1M and 
0.5M concentrations in dH20 prior to mixing with purified PNA and analysis by native 
gel.  
 
2.2.4 Examination of quaternary structure of proteins 
 
2.2.4.1 MALDI Matrix Assisted Desorption Ionization - Time of Flight mass 
spectrometry Confirmation of quaternary structure of PNA 
 
MALDI mass spectrometry sample preparation.  
 
MALDI mass spectrometry of purified samples was carried out by Dr. Putuma Gqamana 
in the Blackburn lab U.C.T, the aim being to establish whether the protein structure and 
size changes were due to pH, as well as whether there was any N-terminal proteolysis 
occurring. 
 
Typically, minimum concentrations of 0.1 mg/mL were required in order to observe 
high-quality spectra for the intact protein by matrix-assisted laser desorption/ ionization 
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mass spectrometry (MALDI MS). Hence, the protein extract was further purified and 
concentrated to the desired volume by buffer exchanging with HPLC grade water, or an 
appropriate pH buffer in the case of pH studies, using the 3 kDa molecular weight cutoff 
(MWCO) Nanosep® ultracentrifugation devices (Pall Corporation). 
 
Purified protein samples were then buffer exchanged into 0.1 M Ammonium acetate 
buffers; pH 3,  7 and  9 using Vivaspin desalt spin columns (GE Healthcare Life 
Sciences,# 28-9322-18) . Proteins were used from concentrated form or at 1:10 or 1:100 
dilutions. Columns were washed with 500µl water. The sample was then added to the 
column and centrifuged for 10 min at 14000rpm, leaving a residue of 100µl of 400µl 
ammonium acetate at the concentration of required pH range was then added and the 
tube was spun at 14000rpm for ten minutes leaving a residue of 100µl; this was repeated 
once, after which the samples were diluted to a final volume of 500µl, by addition of 
400µl 0.1M ammonium acetate.  
 
Thereafter, 0.5 µL of the purified, buffer-exchanged PNA sample was spotted on a 384 
Opti-TOF 123mm x 81mm plate (MDS Sciex, Ontario, Canada), overlaid with equal 
volume of saturated α-cyano-4-hydroxycinnamic acid (CHCA) matrix solution (on the 
order 5 – 15 mg/mL in 30:70 (v/v) 0.1 % aqueous trifluoroacetic acid (TFA) /acetonitrile 
(ACN) solution). The spots were vacuum-dried at room temperature and analyzed by a 
4800 MALDI TOF/TOF™ Analyzer in the high mass linear mode with external 
calibration using BSA (66, 431 m/z units)   
  
2.2.5 High Performance Liquid Chromatography (HPLC) 
 
High-performance liquid chromatography (HPLC) is a chromatographic technique used 
to separate mixtures of compounds in chemistry biochemistry/biotechnology with the 
purpose of identifying, quantifying and purifying the components of the mix individually. 
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It is also useful in establishing quaternary structure of purified proteins. Size exclusion 
chromatography, or SEC, is used primarily for the analysis of large molecules such as 
proteins or polymers and SEC, works by trapping these smaller molecules in the pores of 
a particle; The bigger molecules will simply pass by the pores, as they are too large to 
enter the pores. Larger molecules therefore flow through the column quicker than smaller 
molecules. 
 
The wildtype (wt) PNA purified proteins, were prepared at a concentration of ~ 1mg/ml.  
Purified protein samples were buffer exchanged into either citric acid (pH 3), sodium 
phosphate (pH 7) or -Tris (pH 9) buffers respectively. For HPLC analysis by SEC the 
mobile phase used was sodium phosphate at 0.1M in pH 8 buffer. A sample volume of 
50µl was loaded at roughly 1mg/ml onto the column (Waters Biosuite 250 7.5 diameters 
/ internal 3mm length instrument) where a maximum load volume of 200µl can be used. 
Prior to analyzing the N20 (wild type) sample, the protein was centrifuged to remove 
any residue/precipitants and filter sterilized to avoid clogging the HPLC column.  Eluted 
protein was monitored at 215 and 280 nm where, 215 corresponds to peptide bonds and 
280 to aromatic residues absorption, respectively (tyrosine, tryptophan and 
phenylalanine).As the control samples BSA and Concanavalin A were prepared at 











2.2.6 Affinity binding assay 
 
Antibody labeling and streptavidin coating of glass slides and antibody labeling Cy5 
his and Cy5 PNA 
 
2.2.6.1 Preparation of Cy3-BSA and Cy5-biotin-BSA or for Anti HIS/Anti PNA 
antibody Cy5 labeling 
 
To establish the labelling of BSA with Cy5-labelled antibody, 500 μl of 10 mg/ml BSA 
in PBS pH 7.4 was aliquoted into two separate 1.5ml plastic tubes. 0.5 mg of Biotin-
NHS ester was added to one tube at a 1 mg/ml final concentration. The tubes were 
incubated for 4 hrs at room temperature, on a platform shaker to enable the biotin-NHS 
to react with amine groups on the BSA in the one aliquot. A total of 2 mg each of the 
biotin-BSA and un biotinylated BSA from each of these tubes (in the original buffer and 
concentration) were added to two separate foil-wrapped tubes of Cy5 dye powder 
(#PA23001, GE Healthcare). The vials were vortexed to ensure complete dissolving of 
the content of the vials, and the vials were then incubated for an hour at RT with 
vortexing after every 10 minute interval. After incubation, unbound Cy5 dye was 
removed by applying the samples to Sigma Spin Post-Reaction Purification Columns 
(#S5059, Sigma Aldrich) as per manufacturer’s instructions for Cy-labelled DNA. 
Aliquots of Cy5-BSA and Cy5-biotin-BSA were stored at -20°C for later use.   
  
Anti His and anti PNA were also labelled in the same manner, but a total of at least 1 
mg/ml of antibody is added to each foil wrapped vial due to light sensitivity of the dye as 
exposure to light will compromise the activity of the antibody. Vials were incubated for 
an hour with 10 min vortex bursts. These were applied to Sigma spin columns and the 
protocol followed as described above.  
 
Spectrophotometry assays were carried out to determine the dye-to-protein (D/P) ratio, 
44 
 
to ensure that adequate Cy5-labelling had been obtained, which, as per the 
manufacturer’s information, should optimally be ≥ 2. This is especially important in the 
case of the Cy5-biotin-BSA, which was initially reacted with biotin prior to dye 
labelling, as both labels will react with amine groups on the protein surface. This ratio 
can be calculated by measuring the protein’s absorbance at A280 and the dye absorbance 
at A552 (8% of the dye’s A552 reading is then subtracted from the A280 reading to correct 
for the dye’s absorbance at A280). However, the A280 measurement requires large 
quantities of the protein sample unless micro volume cuvettes are accessible. Therefore, 
a Bradford standard assay was carried out at A595 instead to determine the BSA 
concentration. No absorbance of the dye at A595 was observed.  
 
The concentrations of the BSA and the dye were determined and the D/P ratio was 
calculated (molar dye concentration/molar BSA concentration) using a MW of 66.43 
kDa for BSA and an extinction coefficient of 0.25 μM-1.cm-1 for Cy5. A D/P of 21 was 
observed for Cy5-BSA, while a D/P of 29 was found for Cy5-biotin-BSA. The reason 
for the higher D/P in the case of biotin-BSA was not determined. A concentration of 
2mg of both Anti His and Anti PNA was also prepared as described above. The Anti His 
antibody D/P was calculated to be around 19.9 D/P. whilst Anti PNA was shown to have 
a D/P of around 2.12. 
 
2.2.6.2 Streptavidin coating of glass slides and antibody labeling Cy5 Anti His and 
Cy5 Anti PNA 
 
Preparation and testing of home-made streptavidin-coated array surfaces 
 
A vial of streptavidin lyophilisate (#S0677, Sigma Aldrich) was equilibrated to RT. The 
lyophilisate was then dissolved in water to ~ 10 mg/ml and the reconstitution was 
allowed to proceed for 30 min. The solution was divided into 1 mg aliquots and stored at 
–20°C.  A 1 mg/ml working solution was prepared in 1 x Spotting Buffer (final 
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concentrations of 100 mM KCl, 0.01% Triton X-100, 25 mM HEPES pH 8.5) as needed. 
Care was taken that the Spotting Buffer had a pH > 8.3, as this was necessary for the 
protein amine groups to remain mostly un-protonated and reactive towards amine-
reactive groups on the slide surface 
 
Preparation of streptavidin-coated slides for microarray printing 
 
A Nexterion Slide P (or H) microarray slide was equilibrated to room temperature for an 
hour and removed from the foil packaging. A 1mg/ml streptavidin solution in 150mM 
Na2HPO4 buffer (pH 8.5) was made up and glass microarray ‘lifterslip’ was placed over 
the microarray surface. 60µl of the streptavidin solution was pipetted along the edge of 
the lifterslip in order for the solution to be drawn under the cover slip uniformly by 
capillary action. Slides were then left for 1hr at room temperature in a humidified 
chamber. The lifterslip was removed and the slide washed for 1hr at room temperature 
in 10ml 150mM Na2HPO4 buffer (pH 8.5) containing 50mM ethanolamine to deactivate 
any remaining amine-reactive groups. The slide was washed for 3 x 5 min in 10ml wash 
buffer and then for 5 min in 10ml water.  The slide was placed in a 50 ml Falcon tube 
and centrifuged at 1000rpm for 1 min at 20°C to spin dry. The newly streptavidin-coated 
slides were placed into slide boxes and sealed in Ziploc bags and stored at -20°C. 
 
Testing of binding specificity to streptavidin-coated slides 
 
The slides were removed from -20°C storage and equilibrated to RT for 1 hr. Cy5-BSA 
and Cy5-biotin BSA were diluted 1:1250 (~6 ng/ml) in 1 x Spotting Buffer. Two slides 
each were incubated in Cy5-BSA and Cy5-biotin-BSA for 30 min at RT on a platform 
shaker. The slides were then washed 3 x 5 min in PBST (0.1% Tween-20 in 1 x PBS pH 
7.4) and 1 x 5 min in dH2O with shaking. Slides were spun dry at 1000 rpm for 5 min 
and scanned at 120 PMT at 10 μm resolution.  
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Testing of coating homogeneity across slide surface 
 
After each fresh batch of streptavidin-coated slides was prepared, a batch quality control 
test was performed to determine whether the homogeneity across the slide surface was 
adequate. One to two slides from each batch (depending on batch size) were incubated 
with Cy5-biotin-BSA and then washed, spun dry and scanned (as described for the 
binding specificity test above). Using GenePix Pro measuring tools, a rectangular region 
of 22 x 58 mM (the active area of the slide) was drawn. The average and median pixel 
fluorescence and the standard deviation across this area were then calculated. The same 
measurements were also performed for a rectangular region of 7 x 7 mM to determine 
homogeneity across a smaller area.     
 
Establishing uniformity of the streptavidin derivitisation. 
 
A single streptavidin-coated slide was equilibrated to room temperature and washed for 
1 min in 150mM Na2HPO4 buffer (pH 8.5) then centrifuged briefly (1000rpm; 1 min) to 
remove excess surface liquid. 1mg/ml solution of Cy5-labelled, biotinylated BSA in 
150mM Na2HPO4 buffer (pH 8.5) was prepared.  
 
A glass microarray ‘lifterslip’ was placed over the microarray surface and 60µl of the 
Cy5-labelled; biotinylated BSA solution was pipetted along the edge of the lifterslip 
such that the solution was drawn under the cover slip uniformly by capillary action.  
 
The slide was incubated for 1hr at room temperature in a humidified chamber after 
which the lifterslip was removed and the slide washed for 3 x 5 min in 10ml PBST, then 
centrifuged briefly (1000rpm; 1 min) to remove excess liquid. The slide was then 
scanned in a fluorescence microarray scanner (excitation 550nm; emission 570nm; set at 
10 uM resolution and automatic gain control) and the uniformity of fluorescence across 
the slide determined.  
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An alternative method was also employed whereby all steps requiring lifter slips 
covering the slides were instead replaced by immersing the slides in around 10 ml of 
each solution required at incubation or wash steps. These slides were shaken on an 
orbital shaker for different time incubations and wash steps required. 
 
2.2.7 Microarray assay –Protein-Carbohydrate binding assay 
2.2.7.1 Hand spotting streptavidin coated slides 
 
Prior to the preparation of the slides for hand spotting the microarrays, the lyophilised 
Biotinylated Polysaccharide Sugars were resuspended at 1mg/ml in 50mM phosphate 
buffer each sugar, i.e Lactose, N-acetylactoseamine, and the Thompson Fredenreich 
antigen (T-antigen) were diluted into 50mM Sodium Phosphate buffer with 20 % glycerol 
to 1mM concentrations. These sugars were then further diluted to 200uM as a working 
solution.  
 
Streptavidin coated slides were removed from -20°C storage and allowed to equilibrate 
to room temperature. Using a hand spotting template, 1ul of sample of biotinylated sugar 
was spotted onto the slide surface in increasing concentrations across each slide with a 
range of 1mM to 100nM, (1mM, 1uM, 100uM, 100nM) including spotting 1ul of a 
buffer only control. Biotinylated Cy5-labelled BSA as also spotted as a positive control 
(Figure 2.1). 
 
These hand spotted slides were incubated for 30 min at room temperature. Slides were 
then washed 3x5 min in 1x PBS supplemented with 100 µm Biotin and 0.1mg/ml BSA 
in order to remove excess unbound sugar on the surface and to block any residual biotin 
binding sites. Varying concentrations of protein; wildtype (wt) PNA, PNA (I101R) or 
PNA (N41R)   ranging from 100µM to 100nM were placed underneath a lifter slip 
above the hand printed slide, or alternatively allowed to wash over the slide 
continuously with slow movement. 
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If incubated under a lifterslip, about 50µl liquid was needed to cover the slide. If 
proteins were spotted in areas allowing a 16 well gasket to fit over the spots, then each 
resultant 16 plex well needed to be incubated with 50µl of protein at the desired 
concentration. Each protein was diluted in the 1 x Elution Buffer (see Protino elution 
buffer in Materials and Methods section). The slides were incubated with PNA for one 
hour and then washed in PBST for 2 x 5 minutes. In this case, we employed the use of a 
lifterslip to allow the protein to wash across the slide. 
 
Fluorescently labeled Primary antibody was prepared at the required dilution of 1:1000 
in a 5% milk powder solution in PBS.  Enough antibody was prepared so that, the 
slides could be incubated with the antibody in a container able to hold about 15ml of 
antibody dilution; alternatively using the 16 plex gasket, 50ul of Ab solution was 
added to each well and incubated in  the dark overnight at 4°C.  
The slides were then washed in 3 x 5 min PBST (0.05% Tween20 in 1 x PBS)- followed 
by a single 5min wash in dH20 and slides were then spun dry in a 50ml Falcon tube at 
500-1000rpm for 1 minute at 20 ºC to dry. Scanning was performed at the desired 120 
PMT voltage at the CPGR on a TECAN reloaded microarray scanner.  
 
 
Figure 2.1. Hand spotted array. Slides that were hand spotted with sugars were plotted in the 
following manner incorporating both positive and negative control spots and varying dilutions of 
sugar.  Lactose, Nacetylactoseamine or T-Antigen and washing with either pCES N20, pCES I101R 
or pCES N41R. BSA spotted with a Cy5 fluorescent label. Sugars were diluted from a 1mM stock 
solution of each sample. 
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2.2.7.2 Microarray printing 
 
Streptavidin coated slides were removed from 20 ºC freezer and equilibrated at room 
temperature for an hour before washing in 10mM sodium phosphate solution for 10 
minutes. Slides were spotted by hand and spotting 1µl of each sugar on the slides at 
varying concentrations, or the spotting by microarray, printed abstractly on a Q Array 2 
printer  (Genetix) at the following conditions (fig.2.2) and dilutions of the sample to be 
printed was prepared according to the pattern in Figure 2.2. The slide is left in the 
humidifier after printing, for 30 minutes Q Array 2 (Genetix).  Each sugar was prepared 




Figure 2.2. Arrangement of print of sugars onto slide. Layout of microarray printed format. 
 
One printed slide was initially scanned under automatic gain control after printing of the 
sugars, to determine whether there was any auto fluorescence of the biotinylated sugars. 
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The slide pattern was arranged in a 16- plex format, with each area consisting of nano 
liter volume spots of each sugar, allowing for a larger number of sugar dilutions to be 
printed reproducibly across each 16 plex area. The slide was washed and then blocked in 
5 % skim milk powder in PBS supplemented with 100µM Biotin at room temperature 
with gentle agitation. 100 µM of each PNA variant was prepared, 50µl of each protein, 
was added to individual wells and the side incubated for 1 hour at room temperature. 
This procedure was repeated across varying protein concentrations with each unique- 
protein/ concentration combination being added to a discrete replica 16 plex microarray. 
Slides were then blocked for 30 min in 5% milk powder in PBS at RT and then washed 
in 1xPBST and probed with an appropriate Cy5 labeled antibody (either Cy5 Anti His or 
Cy5 Anti PNA) at optimized concentration of 1:1000 in 5% milk powder PBS for one 
hour in the dark at RT.  Slides were then washed: 3x5min PBST followed by one wash 
in distilled water, the slide was spin dried in a 50ml Falcon tube at 500rpm for 2 minutes 
at 20 ºC to dry and scanned as before. 
                
Figure 2.3. Print layout for each replica 16 plex array. 
The slide orientation for each well (16wells) was prepared in this orientation to allow broad range of sugar 




In Figure 2.3 each protein was prepared from 1uM through to a lowest concentration of 
50nM. One 16-plex array was used for a buffer only control. In the first instance varying 
concentrations of protein and sugar were employed in order to determine whether 
binding was taking place, initially only one concentration dilution of antibody was used 
to determine whether there was binding and then later on the antibody concentration was 




Figure 2.4. Illustration of the assay. This format was used to determine the optimal antibody 
concentration and incubation time.  
 
Figure 2.4 Above illustrates one of many attempts to establish the best assay conditions. 
In this instance we evaluated various primary antibody concentrations at two different 
52 
 
protein concentrations. This was aimed at identifying which antibody dilution gave the 
least amount of background and best foreground fluorescent signal for subsequent 
binding assays. Three slides were prepared in this manner in order to assay all three 
proteins. This assay made use of 2 protein concentrations down each side of the slide. 
Each biotynylated sugar was prepared at 5 different concentrations (500µM, 200 µM, 
100 µM, 10 µM and 100nM) along with a control sample (buffer only) and a Cy5 BSA 
sample (provided and prepared by Dr. Aubrey Shoko as a gift to us).  Each spot was 
printed in duplicate at nL ranges across each individual well. Every printed assay was 
prepared in this manner, with the only changing parameters being varying the protein 
concentrations that were washed across the slide as well as the antibody concentration. 
Figure 2.4 displays the layout of each well with the variation of the incubation times of 
each antibody concentration used and the use of the two different protein concentrations 
used here. 
 
2.2.8 ELISA Enzyme-linked Immunosorbent assay  
 
This experiment required pure protein and biotinylated carbohydrates i.e. T-antigen 
Lactose and LacNAc. NHS activated PEG (Poly-ethylene glycol) coated 96 well plates, 
were derivatised with 1mg/ml streptavidin for an hour at room temperature.  
 
Streptavidin was then removed and the wells washed in 100ul of 1xPBS buffer. 100uM 
of each carbohydrate (50ul) was added to individual wells and incubated for an hour at 
room temperature. Wells were then washed in 100ul of PBS and blocked in 1mg/ml BSA 
for an hour. All liquids were aspirated with a pipette to remove any remaining liquid in 
the well. Sugar derivatised wells were then incubated with appropriate PNA variants at 
varying concentrations (3 µM, 1.5 µM, 0.75 µM, 0.3 µM, 0.18 µM, 0.09 µM, 0.04 µM, 
0.02 µM) as per table 2.2 for an hour at room temperature, wells were washed with 100ul 
1x PBS and incubated with 50µl of 1:1000 dilution of primary Anti His antibody HRP 
conjugate for an hour.  Wells were then washed (3 x 1 minute) with 100ul PBST, 
followed by one water wash. Substrate (Substrate Reagent Pack, R&D systems catalogue 
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# DY999) was added and incubated for 20 minutes in the dark. Reaction was promptly 
stopped following the addition of 1M H2SO4 to stop the reaction here. The microwell 





Table 2.1 .The steps of the ELISA assay are described. 
Microwell derivitisation (step 1); addition of biotinylated sugar (step 2) ; addition of PNA variant (step 3); 
addition of Primary antibody (step 4); the combinations of sample set up in each well and of these varying 
concentration of each sample was analysed on PEG and high binding plates to determine which gave best 
signal when read on microplate reader at450 nm. Blocking attempts were made with milk powder, 1mg/ml 
BSA with 1mg/ml Biotin, 5% milk and 1mg/ml BSA 
.  
    STEP 1                           STEP 2                    STEP 3                        STEP 4 
--------------- sugar protein antibody  
Streptavidin ------------------ protein antibody 
Streptavidin- sugar -------------------- antibody 
Streptavidin- sugar protein -------------------- 
Streptavidin- sugar --------------------- antibody 
Streptavidin sugar --------------------- -------------------- 
---------------- sugar --------------------- -------------------- 







The initial steps taken, prior to the first proper ELISA, performed, involved a process of 
elimination to determine whether our sugars, proteins, antibody or the streptavidin was 
causing any auto fluorescence. In table 2.1 above, the inclusion or absence of a specific 
parameter was examined to test for any auto fluorescence. 
 
Table 2.2.The steps of the ELISA assay are described. Arrangement of sugar concentrations, and 
protein concentrations used. 
   
    
 
   
    
The table (2.2) above as previously referred to, displays the arrangement of the 
sugars, their concentrations and the varying PNA concentrations used in this 
experiment.  
 






Chapter 3: Results and discussion 
 
3.1 DNA preparation 
 
3.1.1 DNA extraction and quantification 
 
Plasmid preparations using Qiagen purification kits yielded substantial amounts of DNA 
with ranges of between 100- 200ng/ul for each 5ml start culture. To improve yields, 
Zymogen® kits were used to concentrate DNA further, to ensure sufficient sample for 
separation on agarose gels and for further characterization. Upon concentrating, the 
samples yielded between 300- 400 ng/ul of DNA.  
 
3.1.2 Plasmid sequences from DNA extractions for protein expression and 
purification 
 
Historical plasmid constructs pCESN20 (6xHis), pCES N41R (6xHis) and pCES I101R 
(6xHis) (Sharpe, 2003) were used to transform fresh E.coli JM109 cells and new plasmid 
DNA was prepared. These constructs contained a Chloramphenicol resistance gene 
thereby making use of Chrolamphenicol resistant antibiotics. Restriction analysis and 
sequencing confirmed clone identities (see section 3.1.5 and appendix for chromatograph 
sequences). These sequence–confirmed clones were used in all subsequent protein 












Figure 3.1. Plasmid map for pCES N20 (Sharpe, 2003) encoding wt PNA.  Plasmid contains a 







Figure 3.2 Plasmid maps for pCES N411R and pCES I101R (Sharpe, 2003). These maps encode 










Figure 3.3. Restriction digests of samples. pCES N20 (6XHis) , pCES PCES I101R, pCES PCES 
N411R.Lane 1 DNA ladder (Fermentas) Lane 4,7,10 is the NdeI/XhoI digest. Lane, 3, 6, 9 NcoI/NdeI 
double, Lane 2, 5, 8 NcoI single digest.   
 
Table 3.1 The expected fragment sizes in base pairs of each restriction digest. 
  
 pCES N20  pCES I101R pCES N41R 
NdeI/NcoI 2422,2241,476 (bp) 2422,2241,476 (bp) 2422,2241,476 (bp) 
NcoI 2717, 2422 (bp) 2717, 2422 (bp) 2717, 2422 (bp) 







3.1.4 Discussion: restriction digests 
 
In Figure 3.3, restriction digestion products were separated on varying percentage 
agarose gels depending on sizes that needed confirmation. Gels were prepared in 1x TBE 
running buffer run at 80 Volts for ~ 2 hours. Restriction digests of plasmid encoding wild 
type PNA and the two mutants displayed the same pattern of digestion for single and the 
two double digestions. Digest sizes for both single and double digest were as follows: 
NcoI (2717bp, 2422bp) NcoI/NdeI (2422bp, 2241bp, 476bp). NdeI/XhoI(4405bp, 734bp) 
( Table 3.1). Restriction digests suggested that the plasmids encoding both the mutants 
and wild type PNA’s were correct, as judged by the observed expected band sizes. In 
some instances incomplete digestion was apparent, presumably due to insufficient or old 
enzyme. It could also be due to impure DNA, phenol or detergent contaminations as well 
as improper dilution or addition of enzyme. 
 
3.1.5 Sequence analysis 
 
Sequencing data (Figure 3.4 and see appendix chromatograph data) confirmed that the 
plasmids were correct as compared to original sequence (Uniprot, accession#P02872). 
Sequence results also confirmed the expected site directed mutations. Figure 3.4 the 
translated sequence of the encoded recombinant PNA’s with amino acid changes at 
positions 41 and 101 in the two variants, are shown. The DNA sequence for the PNA was 
extracted and translated into amino acid sequences. Each protein sequence was aligned to 
the original PNA using SIM - Alignment Tool for protein sequences, Expasy tool. 
Chromatograph data for pCES N20 was not of the best quality, the chromatograph was 






Original protein PNA sequence as per Uniprot entry accession number P02872 




AETVSFNFNS FSEGNPAINF QGDVTVLSNG NIQLTNLNKV NSVGRVLYAM PVRIWSSATG 60   
NVASFLTSFS FEMKDIKDYD PADGIIFFIA PEDTQIPAGS IGGGTLGVSD TKGAGHFVGV 120  
EFDTYSNSEY NDPPTDHVGI DVNSVDSVKT VPWNSVSGAV VKVTVIYDSS TKTLSVAVTN 180  
DNGDITTIAQ VVDLKAKLPE RVKFGFSASG SLGGRQIHLI RSWSFTSTLI TTTRRSIDNN 240  
EKKIMNMASA                                                        249  
Original precursor aligned against wt PNA construct used here. 
AETVSFNFNS FSEGNPAINF QGDVTVLSNG NIQLTNLNKV NSVGRVLYAM PVRIWSSATG 60 N20 
AETVSFNFNS FSEGNPAINF QGDVTVLSNG NIQLTNLNKV NSVGRVLYAM PVRIWSSATG 60 ORIG  
  
NVASFLTSFS FEMKDIKDYD PADGIIFFIA PEDTQIPAGS IGGGTLGVSD TKGAGHFVGV 120 N20 
NVASFLTSFS FEMKDIKDYD PADGIIFFIA PEDTQIPAGS IGGGTLGVSD TKGAGHFVGV 120 ORIG 
 
EFDTYSNSEY NDPPTDHVGI DVNSVDSVKT VPWNSVSGAV VKVTVIYDSS TKTLSVAVTN 180 N20 
EFDTYSNSEY NDPPTDHVGI DVNSVDSVKT VPWNSVSGAV VKVTVIYDSS TKTLSVAVTN 180 ORIG 
 
DNGDITTIAQ VVDLKAKLPE RVKFGFSASG SLGGRQIHLI RSWSFTSTLI TTTRRS     236 N20 
DNGDITTIAQ VVDLKAKLPE RVKFGFSASG SLGGRQIHLI RSWSFTSTLI            236  
 
 
Sample  identity  “wild type”  pCES N20(6XHIS) 
MHHHHHH… 
1   AETVSFNFNS FSEGNPAINF QGDVTVLSNG NIQLTNLNKV NSVGRVLYAM PVRIWSSATG 
61  NVASFLTSFS FEMKDIKDYD PADGIIFFIA PEDTQIPAGS IGGGTLGVSD TKGAGHFVGV 
121 EFDTYSNSEY NDPPTDHVGI DVNSVDSVKT VPWNSVSGAV VKVTVIYDSS TKTLSVAVTN 
181 DNGDITTIAQ VVDLKAKLPE RVKFGFSASG SLGGRQIHLI RSWSFTSTLI TTTRRS     
 
100.0% identity in 236 residues overlap; Score: 1206.0; Gap frequency: 0.0% 
 
PNA    1 AETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSATG 
N20,   1 AETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSATG 




PNA   61 NVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIPAGSIGGGTLGVSDTKGAGHFVGV 
N20,  61 NVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIPAGSIGGGTLGVSDTKGAGHFVGV 
         ************************************************************ 
 
PNA  121 EFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPWNSVSGAVVKVTVIYDSSTKTLSVAVTN 
N20, 121 EFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPWNSVSGAVVKVTVIYDSSTKTLSVAVTN 
         ************************************************************ 
 
PNA  181 DNGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSFTSTLITTTRRS 
N20, 181 DNGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSFTSTLITTTRRS 
         ******************************************************** 
 
Sample identity pCES I101R 
MHHHHHH…. 
1   AETVSFNFNS FSEGNPAINF QGDVTVLSNG NIQLTNLNKV NSVGRVLYAM PVRIWSSATG 
61  NVASFLTSFS FEMKDIKDYD PADGIIFFIA PEDTQIPAGS RGGGTLGVSD TKGAGHFVGV 
121 EFDTYSNSEY NDPPTDHVGI DVNSVDSVKT VPWNSVSGAV VKVTVIYDSS TKTLSVAVTN 
181 DNGDITTIAQ VVDLKAKLPE RVKFGFSASG SLGGRQIHLI RSWSFTSTLI TTTRRS  
 
99.6% identity in 236 residues overlap; Score: 1199.0; Gap frequency: 0.0% 
 
PNA   1  AETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSATG 
I101R,1  AETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSATG 
         ************************************************************ 
 
PNA   61 NVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIPAGSIGGGTLGVSDTKGAGHFVGV 
I101R,61 NVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIPAGSRGGGTLGVSDTKGAGHFVGV 
         ************************************************************ 
 
PNA   121EFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPWNSVSGAVVKVTVIYDSSTKTLSVAVTN 
I101R,121EFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPWNSVSGAVVKVTVIYDSSTKTLSVAVTN 
         ************************************************************ 
 
PNA   181DNGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSFTSTLITTTRRS 
I101R,181DNGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSFTSTLITTTRRS 
         ******************************************************** 
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Sample identity pCES N41R 
MHHHHHH…. 
1   AETVSFNFNS FSEGNPAINF QGDVTVLSNG NIQLTNLNKV RSVGRVLYAM PVRIWSSATG    
61  NVASFLTSFS FEMKDIKDYD PADGIIFFIA PEDTQIPAGS IGGGTLGVSD TKGAGHFVGV   
121 EFDTYSNSEY NDPPTDHVGI DVNSVDSVKT VPWNSVSGAV VKVTVIYDSS TKTLSVAVTN   
181 DNGDITTIAQ VVDLKAKLPE RVKFGFSASG SLGGRQIHLI RSWSFTSTLI TTTRRS       
 
99.6% identity in 236 residues overlap; Score: 1200.0; Gap frequency: 0.0% 
 
PNA    1 AETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSATG 
N41R,  1 AETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVRSVGRVLYAMPVRIWSSATG 
         ************************************************************ 
 
PNA   61 NVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIPAGSIGGGTLGVSDTKGAGHFVGV 
N41R, 61 NVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIPAGSIGGGTLGVSDTKGAGHFVGV 
         ************************************************************ 
 
PNA  121 EFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPWNSVSGAVVKVTVIYDSSTKTLSVAVTN 
N41R,121 EFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPWNSVSGAVVKVTVIYDSSTKTLSVAVTN 
         ************************************************************ 
 
PNA  181 DNGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSFTSTLITTTRRS 
N41R,181 DNGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSFTSTLITTTRRS 
         ******************************************************** 
 
Figure 3.4. Amino acid sequences of wt and variant PNA are translated from DNA sequences. 
Clearly indicated in red are the amino acid changes compared to the wild type. Each protein sequence was 
aligned to the original PNA using SIM - Alignment Tool for protein sequences, Expasy tool.  
 
This conserved PNA region has been cloned identically to the precursor however, besides 
the mutations that are highlighted above, the N terminal of the Original sequence i.e.  
‘MKPFCVFLTFFLLLAASKKVDS’ was removed and replaced with MHHHHHH 
which is the 6xHis tag. The original PNA sequence was compared to our sequence to 
confirm sequence homology identity. The purpose of this N- terminal tag being replaced 
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with a HIS tag, was to enable ease of HIS tag affinity purification using the Protino kit. 
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3.2 Protein expression and purification 
 





Figure 3.5. SDS analysis of protein expression and western blot. 
Figure A represents proteins expressed at 30°C, for the wildtype N20, lane 1 and 5, I101R lane 2 and 6 
and N411R lane 3 and lane 7. The amounts loaded on each gel were ~10-15 µg of protein. Only soluble 
fractions of protein were loaded. Figure B displays the western blot analysis of the purified proteins, with 
PNA band’s appearing where expected. 
  
The protein expression of PNA was performed at 37°C initially and then again at 30°C. 
The protein expression image in the figure above was to display how the expression of 





3.2.2 Expression of recombinant PNA variants  
  
The relevant plasmids were introduced into E.coli JM109 cells for expression studies. 
Protein was expressed at 30°C without induction due to the presence of the lac O 
promoter mutation present in these vectors. Total protein yield as per the Bradford 
assay was approximately 1 to 5mg/ml for each sample but this was also dependent on 
the method of lysis employed. Analysis of total crude lysate on a 10% acrylamide gel 
revealed a prominent band at 30kDa; (between 25 and 35 kDa) the expected molecular 
weight of monomeric PNA was ~27.5 kDa (Figure 3.5). Proteins often migrate slightly 
differently in SDS-PAGE gels compared to their predicted molecular mass. Rate of 
migration depends upon the net charge, size and shape and it is generally assumed that 
upon heat denaturation, each protein will adopt an unstructured, globular structure with 
bound SDS. Any subtle variation in any of these parameters will (for example the 
unfolded shape or amount of bound SDS) make them migrate at an apparently different 
molecular weight (Sharpe, 2003).  
 
The recombinant expression of some proteins is found to be temperature dependent and 
increased yield of soluble protein can be observed on decrease in expression/incubation 
temperature from 37° to 30°C (data not shown for 37°C), due to a reduction in the rate 
of protein synthesis and /or reduction in plasmid copy number thereby leading to the 
decrease in the concentration of partially folded intermediates prone to aggregation and 
ultimately to a higher yield of protein in the soluble fraction (Sharpe, 2003).  
 
Here recombinant PNA variants were expressed in 500 ml cultures at 30°C in order to 
maximize the yield of expression of proteins in the soluble fractions. The soluble 
fractions were analysed by SDS -PAGE and, in comparison to the expression at 37°C, a 
much more prominent band was evident at 30kDa, presumed to be recombinant PNA. 
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The gel was also loaded with LB and a non- transformed E.coli cell lysate, as the 
controls in this experiment, which showed a difference in band migration/distribution in 
comparison to the crude PNA lysates (data not shown). Bradford assay was used to 
determine the concentration of protein for each sample and crude protein range was 
found to be between 1 and 5mg/mls; 10ml crude lysate obtained per 500ml culture. 
 
Protein expression was initially very low due to a number of possible factors including 
old glycerol stocks having been used to prepare inoculum and/or inefficient cell lysis. 
The preferred method of lysis involved cell fractionation and sonication. Fresh 
reagents, newly transformed E.coli cells, fresh solutions were therefore prepared in 
order to ensure expression yields were not compromised by external factors. This 
resulted in the improved expression yield of the crude lysate proteins. 
 
3.3 Purification of recombinant PNA variants. 
 
3.3.1 Discussion of eluted samples of purification. 
  
Since the recombinant PNA variants all carried an N-terminal His6 –Tag, proteins were 
purified for crude lysate using the Qiagen, ‘QIA Expressionist’ kit that is specific for 
binding His-tagged proteins with high specificity whilst reducing nonspecific binding 
to the column. This kit allowed for the purification of ~5-10mg of crude lysate proteins 





             
 
Figure 3.6. SDS gel of  protein purification  
Two sets of purification are shown. The first elution is seen in lanes 2, 5 and 8 and the second in lanes 3, 
6 and 9. Prominent bands are evident just below 30 kDa indicative of the recombinant PNA that has been 
purified. This was one batch of purifications with two rounds of elution’s.  
 
Proteins were purified using this kit and figure 3.6 displays the first set of elution’s (2, 
5, and 8) of each protein, and (3, 6, 9) as the second round of elution of the three 
proteins. Nonspecific band’s’ were apparently removed in these steps (second round of 
elution), as the band’s intensity and presence starts to decrease with each wash step. 
 
The proteins were subjected to two sets of elutions  as mentioned, using the elution 
buffer as per kit requirements, and although the protocol suggests 4x 0.5ml elution’s, 
the gel above indicates very strong band’s after two elution’s, with further elution’s 
(not shown above), showing a reduction in nonspecific band’s. The imidazole 
containing elution allows for the purified, His-tagged proteins to be released from the 
beads. Presence of a dominant band at 30 kDa in each eluted fraction apparently 
confirmed the previous assumption that PNA migrates aberrantly heavily on SDS- 
PAGE. 
 
Eluted proteins all ranged from concentrations of 0.5mg/ml to about 2mg/ml and these 
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could be further concentrated using Vivaspin / Zebaspin desalt or Centriprep columns.  
These samples were then stored at 4°C for later use.  
 
The elution profile from the column showed minor contamination with other proteins, 
perhaps due to the column being over-loaded or incorrect ratio of bead to proteins 
resulting in overflowing/overcrowding.  
 
3.4 Western blot analysis. 
 
               
 
Figure 3.7 Lane 1- prestained plus protein ladder.  Lane2-4 crude samples wild type, PCES 
I101R, PCES N41R respectively. Lane 5- 7 elution of purified protein of wild type, PCES 
I101R, PCES N41R respectively 
 
Western blot analysis of crude and purified protein, using an Anti-His antibody, 
revealed strong band’s at 30 kDa, consistent with the Coomasie Blue stained gels, 
where a band of ~30 kDa was observed in both, the crude and purified samples, and 
further confirming the identity of the ~30kDa protein as the recombinant, His –tagged 
PNA seen in Figure 3.7. 
 
This conclusion was further verified by repeating the western blot using an Anti-PNA 
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primary antibody followed by a secondary goat anti-rabbit-HRP conjugated antibody, 
which revealed the same 30kDa band’s (data not shown). These purified preparations 
of wt PNA, PNA (I101R) and PNA (N41R) were deemed of sufficient purity and 















Chapter 4: Investigation of quaternary structure of Peanut agglutinin 
 
4.1 Native gel electrophoresis/mobility shift assay 
 
4.1.1 Native vs denaturing gel electrophoresis 
Denaturing gel electrophoresis is a type of electrophoresis in which the native structure 
of macromolecules and in particular, the quaternary structure is typically not 
maintained. Thus, quaternary structures of proteins cannot be investigated using this 
means. 
Native PAGE separations however are run in non-denaturing conditions with which 
secondary, tertiary or quaternary structure is typically maintained. However, native 
proteins may not separate predictably, since the assumption made in SDS-PAGE 
regarding the size –based mobility of proteins break down because different proteins of 
the same mass can have very different shapes and volumes. Unlike denaturing methods, 
such as SDS-PAGE, native gel electrophoresis does not employ the use of a charged 
denaturing agent. The molecules being separated therefore differ not only in molecular 
mass but in intrinsic charge, and experience different electrophoretic forces dependent 
on the shape of the structure. 
 
Here native gel assays are used to assess the quaternary structure of PNA, given 
preliminary data from Sharpe (2003) suggesting that PNA forms dimers in solution, not 
the commonly assumed tetramers (see introduction). In particular we wished to 
determine whether differing detergent concentrations or differing pH ranges had an 
impact on the quaternary structure of PNA.  The samples loaded included that of a 
prestained protein ladder, unstained Con A, non- denatured wildtype PNA as well as 




Given the problems associated with accurate sizing of proteins on native gels, we 
decided to use Con A- a known dimer of similar monomer size to PNA- and a 
Guanidine- denatured PNA as a control for dimer and monomer mobility on native 
gels. 
 
However, this assay gave rise to smeared bands or no sample band visibility see Figure 





Figure 4.1. Native gel electrophoresis. Only visible bands were those of the - unstained and stained 
ladders. Lane 2-Concanavalin A, Lane 4-untreated wildtype, Lane 5-05uM, Lane 6-1uM, Lane 7 -2uM, 
Lane 8-4 uM, Lane 9-6uM, Lane 9. All prepared at 10ug protein concentrations but no protein bands 








4.2 Investigation of Multimeric States and quaternary Structure using 
Mass Spectrometry and High Performance Liquid Chromatography 
 
4.2.1 MALDI Spectrometry 
 
The investigation of the quaternary structure of the PNA was initially performed by 
means of Matrix Assisted Laser Desorption-Ionisation (MALDI) mass spectroscopy at 
three different pH levels.  Purified wild type PNA was prepared at between 0.001 and 
0.01mg/ml in 0.1 M citrate (pH3), 0.1M phosphate or 0.1M Tris (pH9). For each pH, 
0.5ul protein solution was mixed with an equal volume of acidified CHCA matrix and 
spotted onto a MALDI target plot.  
 
Each resultant protein/matrix spot was then analyzed on an AB Sciex 4800 MALDI 
TOF/TOF mass spectrometer. The resultant Mass spectrometry data revealed the 
apparent monomers, dimers and trimmers at pH 3, dimers and trimers at pH 7, and 
primarily dimers at pH 9. There was no error with the sample concentrations as there 
was some variation between concentrations. Future work would make better use of 















Figure 4.2 Purified PNA at 0.01mg/ml in 0.1M Citric acid buffer pH 3. Analysed using a 
saturated CHCA matrix in acidic 30:70 0.1% TFA(pH2): ACN solution. 
 
 
The predicted exact mass of the wild type His6- tagged PNA monomer is 26.143 Da 
Following calibrations of the AB 4800 using standards Figure 4.2 reveals peaks at 
26,056.014 Da, 52,180.170 Da and 78,408.141 Da, which we interpreted as PNA 














Figure 4.3. Purified PNA at 0.001mg/ml 0.1M Sodium Phosphate buffer in pH 7. Analysed 
using a saturated CHCA matrix in acidic 30:70 0.1% TFA (pH2): ACN solution. 
 
Figure 4.3 indicative of predominantly dimeric species compared to pH 3 samples, this 
pH range shows no evidence of the monomeric species, and strong evidence of an 
apparent trimer. Figure 4.4 shows a similar trend, although here there is weak evidence 












Figure 4.4.Purified PNA at 0.001mg/ml in pH 9 0.1M Tris HCL buffer. Analysed using a 
saturated CHCA matrix in acidic 30:70 (0.1% TFA (pH2): ACN solution. Image clarity could not be 
improved after scan. 
 
Table 4.1 Illustrating the kDa of each species at different pH ranges 
 Monomer Dimer Trimer 
pH 3 26056.0137 52169.5703 78408.1406 
pH 7 N/A 52220.031 78382.0859 
pH 9 26035.5781 52169.8008 78079.2578 
 
Table 4.2. Monomeric species observed at pH 3, 7 and 9 
 





Monomer 26.056.0 N/D 26.035.6 26.143.1 87.1 
76 
 
Ordinarily, MALDI mass spectrometry is considered to be a denaturing technique in 
which protein complexes are not observed. The observation here of a predominantly 
dimeric PNA species at all pHs is therefore interesting and suggestive of a tightly 
bound dimer as the dominant solution- phase species of PNA. The observation of an 
apparent trimeric PNA species by mass spectrometry is perplexing and we do not have 
a robust explanation for this, but suggest that it might represent an artifact of the co-
crystalisation of PNA dimers and monomers with matrix. In the mass spectrometry 
experiments described here, it is worth noting that, whilst it is difficult to measure pH 
in a mixed aqueous: organic mixture, theoretical calculations suggest that the addition 
of an equal volume of 0.1 % TFA (pH 2)/ acetonitrile (30:70 v/v) to a 0.1M buffer will 
not significantly perturb the pH of the buffer solution. (N.B this equate to mixing equal 
volumes of 0.1M buffer with ~2.6 mM TFA). (Note, we are ignoring the effect of the 
organic acid CHCA in the approximations). 
Although it is tempting to calculate ratio of monomer vs dimer vs trimer from the areas 
under the curves under each peak, in reality this is not strictly legitimate because of 
potentially different ionization affinities for each species. We therefore instead decided 
to evaluate and quantify the solution-phase quaternary structure of PNA further by 
analytical size exclusion chromatography. 
The most accurate data here exists with the monomeric data. It is clear to see that the 
mass is relatively consistent in pH 3 and pH 9, but not with the predicted mass of 
monomer. It is however, consistent with the possible loss of a serine on the C- terminal, 








4.3 High performance liquid chromatography (HPLC) analysis of PNA 
quaternary structure. 
 
Size exclusion chromatography was used to further explore the results of the Mass 
spectrometry experiments, which were apparently in accordance with previous 
preliminary data of Sharpe (2003). PNA and various controls were independently 
injected into an analytical size exclusion column at a concentration of ~1mg/ml and the 
elution profile was monitored at 215nm; the elution time was later converted to an 




Figure.4.5 An overlay of chromatography for PNA and two controls, Concanavalin A and 





Figure 4.5 shows the initial chromatogram of wild type PNA overlaid with the 
chromatogram for Con A and BSA samples. At 15 minutes a peak corresponding to the 
monomeric form of BSA (~67 kDa) appeared in its dimeric form.  At 17.5 minutes a 
Con A peak was evident and assumed to be dominant Con A dimer (~50 kDa). The 
PNA (at pH 8) elution peak (~16.5 min) is overlapped with these two control peaks, 
suggesting a molecular weight of between the 50 and 67 kDa and therefore a dimeric 
form of PNA. Table 4.3 shows the elution time and estimated molecular weights of 
PNA and the controls.  
 
Table 4.3 Elution times of PNA and control samples.  Here, their corresponding molecular weights, 
as well as Log value of these molecular weights can be seen. 
 
Protein standards Elution time Molecular weight Log MW 
Void volume ~10.3 min ~170kD-200kDa 2.30 
BSA dimer ~13.13 ~133 2.12 
BSA monomer ~15.25 ~67 1.83 
PNA dimer ~16.5 ~52 1.72 
Concanavalin A dimer ~17.25 ~50 1.75 





Figure 4.6 Standard curves for determination of estimated PNA size. 
The generation of a standard curve was used to provide an indication of the size of the 
PNA in the HPLC experiment. This provided an estimated size of the predominant 
PNA peak is an apparent dimer at pH 8. This standard curve was used for further size 
approximations of our PNA at different pH ranges in figures/ tables to follow. 
 
Table 4.4 The standard curve (Con A, BSA and PNA at pH 8).  Standard curve equation generated 









Dimer 9 ~16.6 ~8.3 1.60 ~40 
Dimer 3 ~17 ~8.5 1.68 ~48 
Dimer 7 ~17 ~8.5 1.68 ~48 
Monomer 9 ~19.68 ~9.84 1.38 ~24 
Monomer 3 ~19.68 ~9.84 1.38 ~24 
Monomer 7 ~19.68 ~9.84 1.38 ~24 




Although we expected/predicted to see sizes of ~52 kDa for the dimeric form of PNA, 
the size estimates here are slightly lower than 52 kDa. Gel filtration does not measure 
mass of molecule but actually its physical size therefore molecules don’t necessarily 
migrate at precisely exactly expected molecular weights. The fact that we’re observing 
it at a lower mobility of ~40 is consistent with a dimer species. It is also important to 
bear in mind that although these approximate times are used, because of a lack of tools 
to export the data and to acquire proper size estimates, the molecular weights seen here 
are still lower than “tetramers” and higher than “monomers”. It can then be assumed 
that these values are, or rather these estimates are the assumed dimers. Table 4.4 shows 
the molecular weights calculated by means of using the formula. Using a different 




Figure 4.7. Standard curve using different proteins. IgG, Lysozyme Phosphorylase B, and 







Table 4.5 Standard curve data for re calibrated column. y= -0.1159x + 3.6926: equation generated 
after re calibration of column. 
 
 Time (min) Elution vol Log MW MW 
IgG 13.5 6.75 2.17 150 
Phosph B 15.5 7.95 1.98 97 
BSA 15 7.5 1.82 67 













Dimer 9 ~16.6 ~8.3 1.76 ~57.5 
Dimer 3 ~17 ~8.5 1.72 ~52.4 
Dimer 7 ~17 ~8.5 1.72 ~52.4 
Monomer 9 ~19.68 ~9.84 1.41 ~25.7 
Monomer 3 ~19.68 ~9.84 1.41 ~25.7 
Monomer 7 ~19.68 ~9.84 1.41 ~25.7 
Tetramer 9 ~14.66 ~7.33 1.99 ~97.7 
 
 
Table 4.5 and 4.6 show the predicted molecular weights of the PNA at varying pH 
ranges, based on a new equation following the re calibration of the column in order to 
investigate whether the sizes that were previously observed in table 4.4 was in fact the 
correct sizes. The curves are based on a different standard curve using proteins IgG, 
BSA, Lysozyme and Phosphorolase B. This suggested a molecular weight closely 
related to the expected size of the dimeric protein (Sharpe, 2003). This curve allowed 
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for a much better estimation of size range of all species of protein. Once again it must 
be emphasized that gel filtration gives and estimation and both curves are within 
experimental error. The use of these four points was preliminary, as this was intended 
to be a range finding experiment. Typically four points are not as good as ten points 
and this could be included in future experiments.  
Figure 4.8.  pH dependency of PNA elution profile from a size exclusion column. Block A and 
B are the 215/280 traces of pH 3 sample, block C and D sample at pH7 and. Block E and F sample at  pH 
9. 
In order to explore the pH dependency of the PNA quaternary structure, various PNA 
samples (1mg/ml) were buffer exchanged into 0.1M sodium citrate (pH3), 0.1M 
sodium phosphate (pH7) or 0.1M Tris (pH9) and then analysed by size exclusion 
chromatography see Fig 4.8. In each case, the column was pre equilibrated in the 
relevant pH buffer and that buffer was also used as the mobile phase during elution. 
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This figure depicts the initial test to determine whether there would be any traces 
appearing on the HPLC. This data is unclear as the run was not a complete success, 
thus requiring the experiment to be repeated in future. 
Figure 4.9 Shows an overlay of the PNA elution profiles at the three different pH’s. Showing 
HPLC output data of the wild type sample showing the overlapping traces of pH 3(blue), pH 7(red) and 
pH 9(yellow). Con A (green) was used as a control sample in this experiment. 
 
Con A sample in solution was a dimeric species. A tetrameric form of Con A would not 
sit well on the HPLC column. This Con A was prepared at pH 8 in 0.1 M sodium 
phosphate buffer and used as a control. The data above suggests the likely presence of 
dimeric as well as monomeric forms of PNA. The presence of largely dimeric PNA is 
seen at pH 9 whereas in pH 7 and pH 3 there appear to be a large presence of 
monomeric PNA (see area under curve, Figure 4.10, 4.11 and 4.12). In order to 
investigate whether the large peak eluting at 22.5 minutes at pH 3 reflected some acid-
catalysed autolysis of PNA, equivalent samples of PNA were pre incubated at either pH 
9 or pH 3 and then analysed on SDS PAGE. Figure 4.9 and 4.13 is an overlay of the 
peaks found at the varying pH ranges thus making the only relevant information, the 
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time overlaps between the samples. Figures 4.10, 4.11 and 4.12 were included to show 
area under curve estimations. This was only because the program could not export the 
data into any other format (i.e. excel) and could only be printed. Area under the curve 
information had to be gathered manually. 
 
 
Figure 4.10 pH 3 citric acid buffer data plotted onto graph paper. The area under curve data was 
manually calculated from this image. 
 
Table 4.7 Fraction of each quaternary structure of wt PNA at pH 3. 
pH3 # blocks Fraction % 
Tetramer / / 
Dimer ~ 3 0.315 
Monomer ~ 6.5 0.68 
Total ~9.5 1.0 
 
Figure 4.10 and Table 4.7 indicate the presence of both dimeric and monomeric species 
of PNA at pH3. The images presented in figures 4.10, 4.11 and 4.12 could be imported 
from the HPLC program as there was no digitized format/program to interpret this 
image. The use of graph paper to plot and calculate the amount/ fraction of each 
species, was because of the absence of an available tool to measure/ calculate the data 
efficiently as the HPLC output only allowed the data to be printed and not exported into 
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a program to calculate. The presence of a peak eluting off the column between ~20 and 
22.5 minutes was puzzling and required some investigation in order to determine its 





Figure 4.11 Graphical representation of pH 7 sodium phosphate buffer data. The area under the 
curve was manually calculated from this curve as is seen in 4.10. 
 
Table 4.8 Fraction of each quaternary structure of wt PNA at pH 7. 
pH 7 # blocks Fraction % 
Tetramer / / 
Dimer ~9.5 0.55 % 
Monomer ~8.5 0.45 
Total 18 1.0 
 
 
Figure 4.11 and Table 4.8 represents the fraction of species upon eluting off the HPLC 






Figure 4.12 Graphical representations of pH 9 Tris HCL buffer data. Area under the curve data 
was also manually calculated as seen in figure 4.10 and 4.11. 
 
Table 4.9 Fraction of each quaternary structure of wt PNA at pH 9. 
pH 9 # blocks Fraction % 
Tetramer ~4.5 0.166 
Dimer ~ 16.0 0.59 
Monomer ~6.5 0.24 
Total 27 1.0 
 
Data represented in figure 4.12 and table 4.9, is that of protein prepared at pH 9 with 
fractions displayed for each species. pH 9 data suggests the presence of predominantly 
dimeric species for this range. There exists less than 20 % of tetrameric form and nearly 
25 % of monomeric protein. In order to investigate whether the large peak eluting at 
22.5 minutes at pH 3 reflected some acid catalyzed autolysis of PNA, equivalent 





Figure 4.13 pH range comparison. This overlay again, highlighting the varying pH ranges but, 






Figure 4.14 SDS PAGE gel to determine presence of contamination. This gel was used to 





This SDS-PAGE gel revealed no other band’s at pH 3 or pH 9 except the expected 
~30kDa band. We therefore assumed that the aberrant 22.5 minute peak reflected a 
contamination in the citric acid buffer. A fresh batch of citrate buffer had been prepared 
for this gel as this experiment was run much later than the initial HPLC analysis since 
the previous batch of citric acid buffer had been discarded. 
 
From the HPLC data shown above, a number of observations can be made. 
At pH 9, the recombinant PNA used in this study is predominantly a dimeric species. 
The broadening of the main peak at both higher and lower elution times may suggest 
that a relatively rapid equilibration between dimer and either monomer or tetramer, but 
if this is time, the monomer and tetramer remain minor species at pH 9. Reasons for the 
discrepancy between the solution phase assays here and crystallographic data (which 
suggest PNA is a tetramer) remain unclear at present, but may reflect an artifact of the 
crystallization process. At pH 7, the proportion of PNA monomer increases, but the 
dimer is still the dominant species (see table 4.8). At pH 3, PNA is now observed 
predominantly in the monomeric form. This pH dependent switch from dimer to 
monomer between pH7 and pH 3 is partially consistent with the protonation of a 
carboxyl acid residue in the dimer interface. One such candidate carboxylic acid 
residue a D168 in Figure 4.15, found in both monomers in the dimer interface. 
However, verification that this residue is indeed the culprit would require a site-
directed mutagenesis study (e.g. to study a PNA (D 168N) mutant that could not be 
similarly protonated/ de protonated as a function of pH) that is beyond the scope of this 
Master’s thesis. Interestingly though, D168 makes a number of hydrogen bonding 
interactions in the dimer interface and it would be reasonable to suppose that these 
might be disrupted on protonation at pH 3, thus potentially weakening the dimer 





     
 
Figure 4.15 The carboxylic acid residue at D168. Circled in red are the D168 residues found in both 
monomers in the dimer interface. (Swiss PDB viewer). 
 
Interestingly, plant vacuoles, where PNA is thought to be processed into its mature 
form and stored, have an acidic pH so the data shown here may prove to have some 









Chapter 5: Affinity binding assays 
  
Affinity binding assays were performed in order to establish whether peanut agglutinin 
was able to bind to streptavidin coated slides, derivitised with biotinylated forms of 
Lactose, N-acetylamine and the T-antigen. 
 
5.1 Streptavidin coating of slides 
 
 Figure 5.1 shows an NHS-activated, PEG–coated glass slides successfully coated with 
streptavidin using the method described (section 2.2.6). The replicate spots seen above 
labeled 1 through 8 are Cy5-biotinylated BSA spotted across each of 16 wells (1 spot 
per well; 1ul/spot). The scanned image of this hand spotted slide showed that the slides 
were efficiently coated with streptavidin and that the Cy5-biotinylated BSA then bound 
efficiently to the slides. Figure 5.1 thus confirms that, whilst improvements in the 
uniformity of streptavidin coating could be achieved in principle, these streptavidin – 
coated slides should already be good enough for qualitative assessment of the binding 









5.2 Antibody labeling 
 
Anti-His and anti-PNA were fluorescently labeled with Cy5 fluorescent dye. Yields of 
antibody were around 19.9 D/P for Anti His and 2.12 D/P for Anti PNA.  
 
5.3 Microarray printing of NHS-activated, PEG–coated glass. 
 
Figure 5.2 Microarray Print layout. Clearly highlighted are the sugar variations, protein 





The use of two antibody concentrations and two incubation times in Figure 5.2 gave an 
indication as to which antibody concentration and incubation time would be best suited 
to the assay. Upon comparing the two antibody concentrations, the use of the 1uM 
concentration of proteins seemed to display very poor signal. The 100nm side of the 
slide also showed the highest variation in foreground as a function of PNA 
concentration and antibody concentration. However, this data did not appear to follow a 
logical trend and moreover proved poorly reproducible, with several replica slides 
showing only fluorescence of BSA and/or high backgrounds. Despite repeated 
attempts, it did not prove possible to create a reproducible, quantitative microarray 
based assay for PNA binding to immobilized sugars. Previous colleagues encountered a 
similar problem and it was suspected that the sugars were being masked underneath the 
PEG surface very quickly before assaying thereby making binding impossible. We 
switched to an ELISA format instead to try and establish whether there was a problem 
with the sugars and/or proteins as well. 
 





































Table 5.1 Showing resultant ELISA data. By comparison the SPR data generated by Sharpe (2003) 
similar binding affinities are observed of wt PNA to the T-antigen, but less apparent distinctions between 








T-antigen 1.5M 1.4M 0.8M 
LacNAc N/D N/D N/D 
Lac N/D 1.4M N/D 
 
 
Table 5.2 Predicted affinities of the wt PNA, N41R PNA, I101R PNA for the T-antigen using 



























 4.2 M 0.78 
 
 
Table 5.3. Predicted affinities of the wt PNA and N41R PNA, for lactose using the bivalent 






















 18.4 M 1.25 
 
By comparison to the SPR data generated by Sharpe (2003) (see table 5.2 and 5.3) we 
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observed similar binding affinities of wt PNA to the T-antigen (Figure 5.3), but less 
apparent differences between the wt PNA and I101R or N41R variants (Figure 5.5 and 
5.7). This data suggests a modest decline in affinity. Despite our best efforts to measure 
binding, the wt and the N41R mutant, was unable to provide decent binding affinities 
and no real discerning results by way of binding for the Lactose and LacNAc.  
 
The resultant data is not of the best quality but the data can still be interpreted with 
caution. Our data suggests that there is not such a wide range of binding affinity for T 
antigen whereas data from Sharpe, 2003 shows about 7/8 fold affinity whereas our data 
shows about a 2 fold affinity. Our data also suggests binding of I101R PNA to lactose 
(Figure 5.6), whereas her work suggests no binding to Lactose for this mutant. Further 
work is needed here to confirm our data. Without having repeated SPR analysis, we are 
unable to verify whether the results obtained were due to technical failures/issues or if 
it is a genuine result. This experiment requires further investigation. 
 
The ligand binding model used to plot A415_sugar/ (PNA) vs A415 here was based on 
a 1:1 binding model generated from our Scatchard plot (see appendix, ligand binding 
assay). The fit of the data is based on the R squared values. Importantly though, whilst 
the ELISA data generated here is incomplete and the quality of the data not as high as it 
could ideally have been, we did observe here, binding of the I101R variant to the 
immobilized lactose, in contrast to the SPR data of Sharpe (2003) where no binding of 
this variant to lactose was observed. This suggests that further studies are needed to 
resolve the differences between the ELISA and previous SPR; in the absence of an SPR 
device locally, it was not possible to conduct this comparison here. However, our data 
does suggest that the dramatically increased specificity of the I101R variant for T-








 By means of expression and purification of the proteins, we were able to perform two 
experiments by which to address our initial experimental aims of the thesis: 
1. To provide further experimental evidence for altered specificity of three variant 
forms of PNA that originated form the work of Sharpe (2003). Our experiments 
were aimed  to address this specificity seen in previous work  and showed some 
evidence of similarity to what was seen in that the PNA variants in that it  
showed no evidence of binding towards LacNAc. However, these results were 
interpreted with caution as the data was not of the best quality data. This could 
be due to differences in the technologies used, but without having repeated this 
experiment using SPR technology, it is impossible to verify whether the results 
obtained were true compared to her data. There could very well have been some 
technical failure on either side or it could be a genuine result generated. Further 
investigation on this is required to verify the results.  
 
This work did show binding affinity towards to T-antigen as previously seen 
(Sharpe, 2003), but the fact that binding of I101R was observed for lactose 
needs to be further investigated as previous data shown by Sharpe, (2003) 
showed no binding of this mutant towards lactose. 
 
2. To determine the multimeric state of PNA under varying experimental 
conditions. The experiments used to discriminate between the multimeric states 
of PNA under altered pH conditions were through the use of HPLC. At pH 9 it 
is seen that the recombinant PNA used in this study is predominantly a dimeric 
species. The broadening of the main peak at both higher and lower elution times 
indicate relatively rapid equilibration between dimer and either monomer or 
tetramer, but at this time, the monomer and tetramer remain minor species at pH 
9. Reasons for the discrepancy between the solution phase assays here and 
crystallographic data (which suggest PNA is a tetramer) remain unclear at 
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present, but may reflect an artifact of the crystallization process. 
 
At pH 7, the proportion of PNA monomer increases, but the dimer is still the dominant 
species (see table 4.8). pH 3, the PNA is now observed predominantly in the 
monomeric form. This pH dependent switch from dimer to monomer between pH7 and 
pH 3 is partially consistent with the protonation of a carboxyl acid residue in the dimer 
interface and one candidate could be the carboxylic acid residue a D168 in Figure 4.15, 
found in both monomers in the dimer interface.  In order to verify that this residue is 
indeed the culprit would require a site-directed mutagenesis study but that is beyond the 
scope of this Master’s thesis. Interestingly though, D168 makes a number of hydrogen 
bonding interactions in the dimer interface and it would be reasonable to suppose that 
these might be disrupted on protonation at pH 3, thus potentially weakening the dimer 
interface and favoring monomer instead. Interestingly, plant vacuoles, where PNA is 
thought to be processed into its mature form and stored, have an acidic pH so the data 




In conclusion this work describes the use of the PNA variants in order to increase the 
selectivity of binding to the T-antigen. It also aims to confirm work done by Sharpe, 
(2003) where her work described the presence of primarily predominant dimeric 
species instead of tetrameric species as seen in literature. These findings need to be 
elaborated on in order to successfully use these variants for specifically selecting for 
the T-antigen. Looking at the aims, we found: 
1. Both mass spec and HPLC confirm PNA is primarily a dimer in solution. These 
findings are based on the use of using neutral pH environments as well as 
varying pH ranges. 
2. HPLC analysis confirms that the multimeric state of PNA in solution is pH-
dependent and suggests D168 as a candidate residue mediating this. 
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3. Contrary to previous SPR data, PNA (I101R) does bind lactose and with similar 
affinity to T-antigen. Further studies therefore needed to explain why this 
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General methods  
 
E.coli strains 
E.coli JM 109 strain (New England Biolabs) genotype: F’ tra D36 pro A B LactoseIq  





[5'-CAT ATG CAT CAC CAT CAC CAT CAC GCC GAA ACA GTT TCC TTC -3’] 
 
pceseq 
[5'-GCC GCC AGG CAA ATT CTG-3’]  
 
Sugars all at ~ 30kDa 
BP Gal-β-1,3-GalNAc -α-PAA-biot  
BP Lac PAA biot 
BP LacNAc-PAA biot 
(PAA refers to the polysaccharide biotinylated derivatives of the sugar) 
 
General Methods  
Preparation of LB Agar Plates 
 
All reactions were performed under standard conditions unless otherwise stated and all 
solutions were prepared using Milli-Q water. All work was carried out using E.coli JM 
109 strain. 
 
LB agar was heated until molten and allowed to cool to ~50 C prior to the addition of 
the appropriate antibiotic. Agar was poured into petri plates (sterile plates) and stored at 
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4 ºC when set. 
  
Growth of Bacteria on Solid Media 
E.coli JM 109 containing the appropriate plasmid was transferred using a sterile wire 
loop onto LB agar with Chloroamphenicol (Cam) at 30 ug/ml, the plates were inverted 
and incubated overnight at 37 C or until single colonies were evident. 
 
Growth of overnight cultures 
A single bacterial colony isolated on LB Cam agar (30 ug/ml) was picked up and 
inoculated into 5ml LB cultures with LB agar Cam for plasmid preparation and 
incubated at 37 C overnight with vigorous agitation 225 rpm and then used as an 
innoculum into 500ml LB agar Cam for incubation overnight  at 30 C. 
 
Preparation of Competent cells 
E.coli JM109 strain was used as a competent cell host for transformations using the 
Rubidium chloride method of preparation. A single colony of  JM 109 was inoculated 
into a 5ml LB and grown overnight with shaking at 37 C starter culture was then used 
to inoculate a 500ml LB culture and grown at 37 C to OD 595  ~ 0.5 for ~3 hours.  The 
culture was allowed to cool on ice for 15 minutes and then transferred to two 250ml 
centrifuge bottles and spun for 10 minutes at 4500 rpm in a Beckman centrifuge in 
order to pellet the cells. The supernatant was poured off and the pellets resuspended in 
30ml total of Tfb I, and then placed on ice for 15 minutes. The cells were spun once 
again for 5 minutes at 4000 rpm and the pelleted cells resuspended in 6ml Tfb II and 
placed on ice. 100µl volume of competent cells was aliquoted into 1.5ml eppendorf 
tubes and stored at –80 C.  
 
DNA Manipulation 
Plasmid DNA was prepared from 5ml overnight cultures using Qiagen Miniprep Kit 




Sequencing was carried out by the Central Analytical Facility, Stellenbosch University 
 
Agarose gel electrophoresis 
 
Agarose concentration Fragment ranges bp DNA ladder 
0.8% - 1% 196-3109 bp 
1.5-2% 90- 3109 bp 
3% 90- 968 bp 
 
Electrophoresis grade agarose was added to 1x TBE buffer dependant on the percentage 
gel required as per fragment ranges. The suspension was boiled in a microwave and 
cooled to ~50 C after which 5ul of EtBr of 10mg/ul added and the molten agarose was 
poured into a gel tray and allowed to set with appropriate comb size. The gels were 
immersed in 1x TBE running buffer until ready to be loaded 
 
DNA ladder at a 2x concentration was loaded into one well to serve as molecular 
weight markers for estimation of DNA fragment sizes. Loaded gels were run at ~100 V 
and stopped just before the dye front reached the bottom of the gel. DNA Fragments 
were visualised on a UV trans-illuminator and the molecular masses assessed by 
comparison to the molecular weight markers. 
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Figure A. Amino acid sequence homology (Manoj and Suguna, 2001). This sequence alignment 




Ligand binding assay 
Protein free +sugar free  =  protein.sugar bound 
Kd = [protein][sugar]/ [protein.sugar]            (1) 
Don’t know [sugar free] but do know that  
[sugar total]=[sugar free]+[protein.sugar bound] 
Substituting for [sugar free] in (1) gives 
Kd [protein.sugar]= [protein] ([sugar total]-[protein.sugar]) 
Kd [P.S]+[p][p.s]=[p][stot] 
 [p.s]= [p][stot]/ (Kd +[p]) 
Now, call [stot] “Bmax”; call [p.s] “B”; and call [p] “F” 
B= F Bmax/ Kd + F 
B Kd + BF= FB max 
B Kd= FB max – BF = F (B max-B) 
 B/ F = B max-B/ Kd = B max/ Kd – B/Kd. 
= scatchard plot. 
Therefore a plot of B/F α B 
Will have a gradient of – 1/Kd 
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